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Holocarboxylase synthetase (HLCS) is the sole human protein biotin ligase in the human 
proteome. Other than its role as a coenzyme to the five carboxylases in intermediary 
metabolism, HLCS and biotin are involved in epigenetic gene regulation and immune 
response. Previously, it was shown that (1) HLCS physically interacts with histone 
methyl transferase EHMT-1 which creates histone H3 lysine 9 methylation (H3K9me) 
marks and biotinylates lysine (K) 161 in EHMT-1, thereby strenghtening the 
HLCS/EHMT-1 interaction; (2) biotin depletion and HLCS knockdown cause a loss of 
H3K9me marks leading to de-repression of long terminal repeats (LTRs) and 
chromosomal abnormalities; and (3) deletion of DNA methylation impairs HLCS-
catalyzed biotinylation events in the epigenome. Here we demonstrate a novel paradigm 
that HLCS contributed to the repression of LTRs through mediating protein/protein 
interactions and synergies between methylation and biotinylation events. We show that (1) 
HLCS interacts physically with the maintenance DNA methyl transferase DNMT1 and 
the methyl CpG binding protein MeCP2; (2) HLCS overexpression causes a 200% 
increase of H3K9me marks in LTRs and a corresponding 84% decrease in mRNA coding 
 
 
for LTRs; and (3) erasure of DNA methylation abrogated HLCS-dependent enrichment 
of H3K9me and transcriptional repression of LTRs. It was thus concluded that HLCS 
mediated the integration of biotin and methyl dependent gene repression signals in the 
epigenome, which was further supported by cell culture studies where biotin and folate 
compensated for each other’s deficiency in the repression of LTR in human Jurkat and 
U937 cells, and interactively regulated the expression of proinflammatory cytokines 
through activation of the NF-κB pathway. We also demonstrate that HLCS is involved in 
cellular immune response by catalyzing biotinylation of the stress inducible heat shock 
protein 72 (HSP72). In screen for detecting novel biotinylated proteins in the proteome of 
the human embryonic kidney HEK293 cells, members of the heat shock superfamily of 
proteins, including HSP72, were overrepresented. At least five lysine residues in HSP72 
are targeted for biotinylation, and HLCS-dependent biotinylation of HSP72 elicited the 
expression of the chemokine RANTES from HEK293 cells. In conclusion, HLCS and 
biotin have major impacts in epigenome and immune function.
iv 
 
ACKNOWLEDGMENTS 
I would like to express my great appreciation to Dr. Janos Zempleni, my research 
supervisor, for his patient guidance, constructive suggestions and enthusiastic 
encouragement during my Ph.D. studies. My appreciation is extended to Drs. Timothy P. 
Carr, Gautam Sarath and Dong Wang, my committee, for their kind advice and assistance. 
 
I wish to thank Samudra, Toshi, Azusa, Luisa, Dave, Mengna, Dandan, Yong, Liz, Scott, 
Daniel and all other lab mates for their great help during the planning and development of 
this research, and for making my life in Lincoln so wonderful. 
 
My sincere thanks also go to Lori Beals, Donna Hahn, Jeannie Pittam, Lori Rausch, 
Jolene Walker, Connie Wieser and all other staff in Department of Nutrition and Health 
Sciences for their kindness and help during the four years. 
 
Finally I would like to express deep gratitude to my husband for his support and to my 
parents for everything. 
 
Jing Xue 
July, 2013 
v 
 
TABLE OF CONTENTS 
LIST OF FIGURES                                                                                                          vi   
LIST OF TABLES                                                                                                            ix  
INTRODUCTION                                                                                                             1 
 Reference                                                                                                               14 
CHAPTER I.                                                                                                                    19 
Reference                                                                                                               42 
CHAPTER II.                                                                                                                   46 
Reference                                                                                                               64 
CHAPTER III.                                                                                                                 66 
Reference                                                                                                               83 
OUTLOOK                                                                                                                       87 
APPENDIX                                                                                                                       92 
  
vi 
 
LIST OF FIGURES 
INTRODUCTION 
Figure 1. HLCS mediates the repression of LTRs.                                                  8   
Figure 2. Retrotransposon translocates between different genomic loci.                9   
Figure 3. Chemical conjugation between active biotin compounds                      12 
CHAPTER I 
Figure 1. Proposed model for HLCS-dependent epigenetic gene repression.       38 
Figure 2. HLCS interacts with both MeCP2 and DNMT1 in vivo.                        39 
Figure 3. HLCS interacts with both MeCP2 and DNMT1 in vitro.                       40 
Figure 4. Transfection with plasmid FLAG/Myc-HLCS produced a stable 
overexpression of HLCS.                                                                        40 
Figure 5. The effects of HLCS on LTR repression dependent on DNA 
methylation.                                                                                            41 
CHAPTER II   
Figure 1. HLCS interacts physically with HSP72 in HEK293 cells.                     58 
Figure 2. HLCS overexpression does not cause an increase in HSP72 expression 
in HEK293 cells.                                                                                     59 
Figure 3. HSP72 interacts physically with HLCS in limited proteolysis assays.  60 
vii 
 
Figure 4. Lysines in HSP72 are targets for biotinylation by HLCS.                     61 
Figure 5. Mutations of biotinylation sites in HSP72 do not affect interactions with 
HLCS.                                                                                                    62 
Figure 6. Biotinylation of wild-type and mutant eHSP72 causes an increase in 
RANTES transcription in HEK293 cells.                                               63 
CHAPTER III 
Figure 1. Synergies among biotin, folate, and chromatin proteins in gene 
repression.                                                                                               79 
Figure 2. The abundance of biotinylated carboxylases depends on biotin in culture 
media in Jurkat and U937 cells.                                                              79 
Figure 3. Folate and biotin can compensate for each other’s deficiency in the 
repression of LTRs in Jurkat and U937 cells.                                         80 
Figure 4. Biotin and folate have opposing effects in the regulation of TNF-α 
transcription in U937 cells.                                                                     81 
Figure 5. Curcumin abrogates the biotin-dependent expression of IL-6 to in U937 
cells.                                                                                                        82 
OUTLOOK 
 Figure 1. Creation of HLCS conditional knock out (CKO) mouse.                      87 
viii 
 
Figure 2. Genotype to comfirm the germline transmission of modified HLCS 
sequence.                                                                                                 89 
Figure 3. Removal of the neomycin cassette and loxP flanked E8 by Flp 
recombinase and Cre recombinase, respectively.                                   90 
  
ix 
 
LIST OF TABLES 
CHAPTER I 
 Table 1. PCR primers.                                                                                            36 
APPENDIX 
 Table 1. (Chapter I) The effects of HLCS on LTR repression dependent on DNA 
methylation.                                                                                                                       92 
 Table 2. (Chapter II) HLCS overexpression does not cause an increase in HSP72 
expression in HEK293 cells.                                                                                             93 
 Table 3. (Chapter II) Biotinylation status of HSP72 and its mutants.                   93 
 Table 4. (Chapter II) Biotinylation of wild-type and mutant eHSP72 causes an 
increase in RANTES transcription in HEK293 cells.                                                       94 
 Table 5. (Chapter III) Folate and biotin can compensate for each other’s 
deficiency in the repression of LTRs in Jurkat and U937 cells.                                       95 
 Table 6. (Chapter III) Biotin and folate have opposing effects in the regulation of 
TNF-α transcription in U937 cells.                                                                                   95 
 Table 7. (Chapter III) Curcumin abrogates the biotin-dependent expression of IL-
6 to in U937 cells.                                                                                                             96 
  
1 
 
INTRODUCTION 
Biotin is a water-soluble vitamin that is found in a wide variety of foods in the form of 
free biotin or protein-bound conjugates. Biotin from dietary sources or synthesized by 
intestinal microflora is absorbed in the intestine through the sodium-dependent 
multivitamin transporter (SMVT) (H. M. Said, 2004), and distributed throughout the 
body, including hepatocytes mainly for storage purpose (H.M. Said, L. McAlister-Henn, 
R. Mohammadkhani, & Horne, 1992), central nervous system where it is able to pass the 
blood-brain barrier (Spector & Mock, 1987), kidney for reabsorption (Baur & 
Baumgartner, 1993), and fetus through placental transportation (Schenker et al., 1993). 
In mammals, biotin is appreciated for its function in intermediary metabolism as it serves 
as the essential cofactor for the five carboxylases: acetyl CoA carboxylase 1 and 2, 
pyruvate carboxylase, propionyl CoA carboxylase and methylcrotonyl CoA carboxylase 
(McMahon, 2002). The covalent binding of biotin to protein lysine residues on the amine 
groups in human is catalyzed by holocarboxylase synthetase (HLCS), which is the sole 
human biotin ligase that is located both in the cell cytoplasm and nuclear (Bao, Pestinger, 
et al., 2011; Bao, Wijeratne, Rodriguez-Melendez, & Zempleni, 2011; Suzuki et al., 
1994). Functional biotinylation of proteins does not limit to carboxylases, for example, 
histone biotinylation has been identified on 12 lysine residues in different histones and 
the biological significance of histone biotinylation in gene repression has been well 
studied (Chew et al., 2008; Gralla, Camporeale, & Zempleni, 2008; Kuroishi, Rios-Avila, 
Pestinger, Wijeratne, & Zempleni, 2011; Pestinger, Wijeratne, Rodriguez-Melendez, & 
Zempleni, 2011).  Another chromatin protein, the euchromatic histone-lysine N-
methyltransferase (EHMT), also is a target for HLCS-mediated biotinylation, which for 
2 
 
the first time directly linked biotinylation to histone methylation events (Li, Hassan, 
Moriyama, & Zempleni, 2013). Recently, a total of 108 novel biotinylation sites has been 
reported in the human embryonic kidney HEK293 cell proteome, using mass 
spectrometry assay, with members of the heat shock protein (HSP) superfamily being 
overrepresented among the novel biotinylated proteins (Li, et al. in preparation). 
Severe biotin deficiency in human leads to a variety of health outcomes, including 
thinning of hair, skin rash, depression, lethargy, hallucination and paresthesias found in 
adults, and the effects are more profound in infants, as represented by delay in 
development (D. M. Mock, 2007; D.M. Mock, 1986). The deficiency of biotin is caused 
by insufficient intake of biotin from food, prolonged consumption of raw egg while, and 
genetic deficiency in biotinidase or HLCS (D. M. Mock, 2007). Sufficient biotin intake is 
important for maintaining healthy immune system in that biotin deficiency compromised 
T cell activation and proliferation through regulating the expression and secretion of 
interleukin-2 (IL-2) (Báez-Saldaña, Díaz, Espinoza, & Ortega, 1998; Baez-Saldana & 
Ortega, 2004). The mechanisms causing symptoms of biotin deficiency have yet to be 
fully elucidated, however, it was suggested to be related to disrupted lipid metabolism 
(D.M. Mock, Johnson, & Holman, 1988; Suchy & Wolf, 1986), declined pyruvate 
carboxylase activity accompanied brain lactic acidosis (Diamantopoulos, Painter, Wolf, 
Heard, & Roe, 1986), as well as epigenetic regulation of gene expression by protein 
biotinylation (Chew et al., 2008). Dietary intake of biotin correlates with the abundance 
of biotinylated proteins, based on the evidence that biotinylated proteins such as 
carboxylases rapidly lose the coenzyme biotin in biotin-depleted cell cultures and human 
(Eng et al., 2013; Kaur Mall, Chew, & Zempleni, 2010). 
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This introduction will focus on the biological significance of biotin from following two 
perspectives: one is the epigenetic synergies between biotin and methyl donors, as 
mediated by HLCS in the repression of repeats and the maintenance of genome integrity; 
the other is the biotinylation of the heat shock protein 72 and its role in activating 
intracellular signaling cascades for immune response. 
HLCS interacts with DNA and histone methylation machineries. 
DNA methylation in vertebrate mammals is the covalent binding of methyl groups to the 
cytosine within CpG dinucleotides (Bogdanovic & Veenstra, 2009). DNA methylation is 
associated with repressed chromatin status and gene expression, and the genome-wide 
distribution of DNA methylation is dynamic during development, creating a cell-type 
specific pattern in differentiated cells (Brenet et al., 2011; Meissner et al., 2008). CpG 
islands are defined as regions with overrepresented C+G content and CpG dinucleotides 
compared with the background of the genome (Gardiner-Garden & Frommer, 1987). In 
non-embryonic cells, 60-90% of CpG dinucleotides are methylated, whereas CpG islands 
are usually unmethylated to ensure constitutive transcription from nearby or overlapped 
promoters (Bogdanovic & Veenstra, 2009; Jaenisch & Bird, 2003). 
Mammalian DNA methylation is mediated by a family of DNA methyl transferases 
(DNMTs). The maintenance methyl transferase DNMT1 is responsible for adding methyl 
groups to semi-methylated DNA during cell proliferation and maintains the DNA 
distribution pattern through DNA replication (Robert et al., 2003). Both DNMT3A and 
DNMT3B are de novo DNA methyl transferases for difference genomic regions and are 
highly expressed in developing cells for establishing DNA methylation patterns (Okano, 
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Bell, Haber, & Li, 1999). DNMT3L lacks DNA methyl transferase activities and 
cooperates with DNMT3A to establish DNA imprinting (Bourc'his, Xu, Lin, Bollman, & 
Bestor, 2001; Hata, Okano, Lei, & Li, 2002). The functions of different DNMTs are non-
redundant and in most cases independent (Robert et al., 2003). 
DNA methylation changed chromatin accessibility and gene expression through direct 
recruitment of methyl-CpG binding proteins or blocking genomic sequence otherwise 
bound by proteins required for transcription (Jaenisch & Bird, 2003; Watt & Molloy, 
1988). Proteins that recognize and binds to methyl-CpG generally shares a conserved 
methyl-CpG binding domain (MBD), and those proteins include methyl-CpG binding 
protein 2 (MeCP2), MBD1, MBD2, MBD3 and MBD4 (Bogdanovic & Veenstra, 2009; 
Hendrich & Bird, 1998). Not all MBDs are essential for recruiting gene repression 
machineries or specific for binding to methylated DNA, which is determined by the 
presence of the transcription repression domain ( found in MeCP2, MBD1 and MBD2) or 
auxiliary domains for recognition of additional DNA sequences (zinc figure motif found 
in MBD1) (Bogdanovic & Veenstra, 2009). MeCP2 is more abundant and widely 
expressed compared to its counterparts, and interacts with DNMT1 through its 
transcriptional repressor domain to comprise a dynamic machinery for maintaining the 
DNA methylation patterns (Kimura & Shiota, 2003; Kolker et al., 2012). DNA 
methylation does not always lead to gene repression. For example, methylation of the 
chromatin boundary element binding protein releases the connection between an 
enhancer and its nearby promoter, thereby increasing the transcription from the promoter 
(Hark et al., 2000). 
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DNA methylation was demonstrated to be better correlated with the distribution of 
histone methylation marks than the genomic DNA sequence itself (Meissner et al., 2008). 
In mammals, the most well studied histone methylation refers to covalent attachment of 
methyl groups to ɛ-amine group of lysine residues (Murray, 1964), in addition to arginine 
and histidine residues (Greer & Shi, 2012). Methylation of different lysine residues on 
different histone proteins has distinct functions. The active histone mark histone H3 
lysine (K) 4, which is associated with transcriptional initiation, and the repressive mark 
H3K27 are found to be paired indicators for distinguishing among active transcribed, 
bivalent and stably repressed genes (Mikkelsen et al., 2007). Tri-methylated H3K36 
(H3K36me3) correlates with transcriptional elongation and is enriched at transcribed 
coding and non-coding regions (Kim, Kiefer, & Dean, 2007; Mikkelsen et al., 2007). 
Repeat regions in the genome are usually marked by condensed chromatin structure and 
repressed transcription, and different repeat regions are selectively enriched of the 
repressive H3K9, H3K27 and H4K20 methylation marks (Martens et al., 2005a). CpG 
content in the core promoter region distinguishes two classes of promoters with distinct 
chromatin status and expression patterns (Saxonov, Berg, & Brutlag, 2006). Promoters 
with high CpG content tends to be unmethylated and transcribed, and these promoters are 
usually seen in housekeeping genes and highly regulated developmental genes; genes 
with low levels of CpG content in the core promoter region are more likely to be 
methylated and expressed in a tissue-specific manner (Meissner et al., 2008). 
Histone biotinylation is a rare (<0.001% of histone H3 and H4) natural modification 
(Bailey, Ivanov, Wallace, & Polyak, 2008; Kuroishi et al., 2011; Stanley, Griffin, & 
Zempleni, 2001). HLCS is the only protein in the human proteome that catalyzes the 
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covalent binding of biotin to the lysine residues on proteins (Bao, Pestinger, et al., 2011; 
Bao, Wijeratne, et al., 2011; Suzuki et al., 1994). HLCS enters the nuclear and its 
localization in the chromatin is locus-specific despite that it lacks DNA binding domains 
(Camporeale, Giordano, Rendina, Zempleni, & Eissenberg, 2006; Singh, Pannier, & 
Zempleni, 2011). HLCS catalyzes the covalent binding of biotin to lysine residues on 
histone H2A, H3 and H4 and HLCS knock-down leads to apparent loss of biotinylation 
marks on histone H3 and H4 (Bao, Pestinger, et al., 2011; Chew et al., 2008; Pestinger et 
al., 2011; Rios-Avila, Pestinger, & Zempleni, 2012). HLCS is linked with epigenetic 
machineries in gene repression  based on the findings that: (i) HLCS binds to chromatin 
in a punctuate manner; (ii) HLCS directly interacts with histone H3; (iii) histone 
biotinylation marks are found to co-localize with the repressive histone methylation 
marks (Bao, Pestinger, et al., 2011; Chew et al., 2008).  
Biotin status and histone biotinylation marks has been linked to the chromatin status and 
expression of long terminal repeats (LTRs) in the human genome (Chew et al., 2008). 
Evidence shows that both biotin depletion in culture medium and HLCS deficiency 
caused by genetic deficiency correlate with increased transcription of LTRs and 
decreased enrichment of H3K9me2 marks in LTR (Chew et al., 2008). The binding of 
HLCS to chromatin at specific location as indicated by enrichment of histone 
biotinylation marks relies on prior DNA methylation, and biotin depletion has no effects 
on the level of DNA methylation (Chew et al., 2008). The association between biotin, 
HLCS and histone methylation events was further investigated and it was demonstrated 
that (i) HLCS physically interacts with the histone H3 lysine-9 methyltransferase 
EMHT1 and the in vitro biotinylation of EMHT1 by HLCS enhances the interaction (Li 
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et al., 2013); (ii) HLCS physically interacts with the maintenance DNA methyl 
transferase DNMT1 and MeCP2, and mediates the repression of LTRs through recruiting 
EMHT1, thereby creating the repressive H3K9me3 marks at the locus for gene silencing 
(Figure 1) (Xue, Wijeratne, & Zempleni, 2013).  
The transcriptional repression of LTRs in the genome is ensured by condensed chromatin 
structure, DNA methylation and enrichment of repressive histone methylation marks 
(Martens et al., 2005a). However, an appreciable number of  LTRs have been found to be 
transcriptional active in the human genome (Buzdin, Kovalskaya-Alexandrova, 
Gogvadze, & Sverdlov, 2006; Mikkelsen et al., 2007), and mount the risk for interrupted 
gene expression as de-repression of LTRs enables retro-translocation of the LTR-
containing retrotransposon and increases the rates for spontaneous mutations in the 
genome (Figure 2) (Kazazian, 2004; Martens et al., 2005b; Waterston et al., 2002). A 
great variety of human diseases have been linked to retrotranspositions in the genome, 
including breast cancer and colon cancer (Kazazian et al., 1988; Miki et al., 1992; Morse, 
Rotherg, South, Spandorfer, & Astrin, 1988).  
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Figure 1. HLCS mediates the repression of LTRs. (A) DNMT1 maintains the DNA 
methylation patterns by adding methyl groups on semi-methylated DNA nearby LTR 
genomic locus, which recruits MeCP2 to bind to methylated CpG; (B) HLCS locates 
LTR in the genome through direct interaction with MeCP2 and DNMT1, and further 
recruits EHMT1; (C) HLCS biotinylates EHMT1 which strengthens the association 
between HLCS and EHMT1, the latter creates H3K9me3 marks; (D) the enrichment of 
H3K9me3 at LTRs inhibits the transcription from their promoters.  
 
 
 
A. B. 
C. D. 
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Figure 2. Retrotransposon translocates between different genomic loci. The de-
repression of LTRs activates retro-transcription from its promoter, allowing its associated 
retrotransposon to be transferred from the donor loci to recipient loci in the genome. 
(Adapted from Lewin, 2004) 
 
HLCS biotinylates extracellular HSP72 (eHSP72) and activates intracellular 
immune response. 
During a genome wide screening for biotinylated proteins in the human embryonic 
kidney HEK293 cells, 108 novel biotinylated sites were discovered, and a significant 
large proportion belongs to the HSP superfamily. HSPs are a group of highly conserved 
proteins that are found both in prokaryotes and eukaryotes, and different HSPs that are 
present in a variety of cellular organelles play fundamental roles in orchestrating cellular 
activities (Kiang & Tsokos, 1998). Among the mammalian HSPs, the heat shock protein 
70 kDa (HSP70) family is highly conserved and thoroughly-studied (Asea, 2005). The 
HSP70 family is composed of four members, each with distinct cellular localization and 
function: (i) the 78 kDa glucose regulated protein (GRP78) exclusively localizes in the 
endoplasmic reticulum (ER) and regulates protein processing and secretion through the 
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ER; (ii) the 75 kDa GRP75 was found to localize in mitochondria, and is responsible for 
cell proliferation and aging; (iii) the 73 kDa GRP73 localizes in the cytoplasm and 
nucleus, facilitates folding of nascent peptides as a protein chaperone, and is also 
required for recycling of the vesicles; (iv) the stress-inducible HSP72 is broadly 
distributed, as it is found in cytoplasm, nucleus and extracellular space, and constitutes a 
cellular stress-responsive machinery (Asea, 2005; Mambula, Stevenson, Ogawa, & 
Calderwood, 2007). 
The HSP70s share three major functional domains: an N-terminal ATPase domain of 44 
kDa, immediately followed by a substrate binding domain of 15 kDa, and a little-studied 
carboxy-terminal variable domain weights about 10 kDa (Bukau & Horwich, 1998; Ohno, 
Kitabatake, & Tani, 2004). The HSP70s are most recognized as protein chaperones, as 
they form the cellular machineries in assisting protein folding under varieties of 
conditions, e.g., prevention of protein aggregation and assisting refolding of misfolded 
proteins under stressed conditions, and guidance of protein translocation and assisting 
nascent protein folding and protein turnover under normal conditions (Hartl, 1996). The 
chaperon function of HSP70s rely on their featured common structures, as ATP binding 
by the N-terminal ATPase domain alters conformation of the substrate binding domain  
and opens the binding pocket for frequent interaction with substrates, followed by ATP 
hydrolysis and subsequent closing of the binding pocket, for high-affinity binding of the 
substrate (Bukau & Horwich, 1998; Rudiger, Buchberger, & Bukau, 1997). The 
interaction between substrate binding domain and substrate in return accelerates the 
hydrolysis of ATP, demonstrating an allosteric nature of HSP70s in its chaperon function 
(Vogel, Bukau, & Mayer, 2006). 
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In addition to its role as a protein chaperone, HSP72 is highly stress-inducible and is 
involved in cell-protection mechanisms. A great variety of stress conditions have been 
reported to induce increased production of HSP72 protein in the cytoplasm including heat 
shock, heavy metals, viral or bacterial infection, inflammation, autoimmunity (Asea, 
2005). Elevated intracellular HSP72 inhibits the activation of NF-κB pathway and in this 
manner represses the expression of proinflammatory cytokines (Cahill, Waterman, Xie, 
Auron, & Calderwood, 1996).  
Of note, a marked increase in extracellular HSP72 was observed in response to bacteria 
challenge and brief electric shock in rats (Campisi, Leem, & Fleshner, 2003) and  in 
response to treatment of lipopolysaccharides in THP-1 human immune cells (Abboud et 
al., 2008). HSP72 is encoded by the HSPA1A and HSPA1B genes, and both of them lack 
the ER signal sequence, which is required for the ER facilitated canonical secretion 
pathway. It was proposed that HSP72 is released from the cell through three types of 
pathways: (i) leakage by dead cells; (ii) active secretion by forming “blebbing” vesicles 
near the cell membrane; (iii) carriage by endolysosomes which fuse with cell membrane 
to release the included HSP72 into the extracellular space (Mambula et al., 2007). 
eHSP72 functions as a danger signal to the innate immune system and promotes secretion 
of proinflammatory cytokines from immune cells through interaction with cell surface 
receptors, such function being referred to as “chaperokine” activity of HSP72 (Asea et al., 
2000; Campisi et al., 2003; Multhoff et al., 1999).  
While enzymatic biotinylation of protein is mediated by HLCS, the in vitro biotinylation 
through chemical conjugation is achieved by modified active biotin compounds, which 
react nono-specifically with any free amino group in proteins. In such cases, an N-
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hydroxysuccinimide (NHS) or sulfo NHS group is attached to the carboxylic acid group 
on biotin through an ester bond, and the resulting ester is highly reactive. Both chemical 
and HLCS catalyzed biotinylation lead to the modification of lysine residues by a biotin 
molecule through a stable amide bond (Figure 3).
 
Figure 3. Chemical conjugation between active biotin compounds. (A) the chemical 
structure of unmodified biotin, sulfo-NHS conjugated biotin, and a modified sulfo-NHS 
conjugation with elongated chain between biotin and sulfo-NHS. (B) the active sulfo-
NHS-biotin reacts with the amine group on lysine residue to form biotinylated lysine and 
a sulfo-NHS. (Adapted from: http://www.piercenet.com/browse.cfm?fldID=F330F14F-EBCC-
97DB-7F6E-9664D3ACE886#nhsester ) 
 
Although it is commonly assumed that biotinylation of protein does not alter the structure 
or functionality of the protein, evidence suggests that biotinylated protein exhibits 
different properties otherwise not seen in unmodified counterparts. It was demonstrated 
A. 
B. 
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that chemically biotinylated HSP72 binds to HEK293 cells in a saturable manner with 
greater affinity than unmodified HSP72, and that the binding of biotinylated HSP72 to 
cell surface induce the secretion of the chemokine RANTES(Tao, Nishikawa, Nomura, 
Kitabatake, & Tani, 2005). RANTES is essential for the amplification of the T-cell 
mediated immune response due to the fact that its expression is specifically delayed in T-
cells in response to immune activation (Nelson & Krensky, 2001). RANTES is 
implicated in various diseases, including AIDS, atherosclerosis and autoimmune diseases 
and, like other chemokines, it plays an important role in guiding migration of immune 
cells to lesions during immune response (Nelson & Krensky, 2001). In consistent with 
the chemical conjugated biotinylation on HSP72, enzymatically biotinylation elicited an 
increase in RANTES transcription in HEK293 cells in a dose-dependent manner (Xue, et 
al. submitted). In addition, when recombinant HLCS was added to HEK293 cell 
suspensions in the absence of HSP72, RANTES expression also increased, indicating the 
existence of endogenous eHSP72 in the cell culture that are targeted for biotinylation. 
Conclusion 
Biotin, other than its classical roles as cofactor for the five carboxylases in intermediary 
metabolism, has been implicated in epigenetic regulation of gene expression and immune 
response. The following chapters will provide in-depth investigations of the underlying 
mechanism of the (i) HLCS-dependent epigenetic synergies between biotin and methyl 
donors in repression of repeat sequences; (ii) endogenous biotinylation of HSP72 and its 
effect in inducing RANTES production and (iii) synergies between biotin and folate in 
the regulation of the expression of inflammatory cytokines from the myeloid lineage 
human U937 cells and the lymphoid lineage human Jurkat cells.  
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Abstract 
Holocarboxylase synthetase (HLCS) is a chromatin protein that facilitates the creation of 
histone H3 K9-methylation (H3K9me) gene repression marks through physical 
interactions with the histone methyl transferase EHMT-1. HLCS knockdown causes a 
depletion of H3K9me marks in mammalian cell cultures and severe phenotypes such as 
short lifespan and low stress resistance in Drosophila melanogaster. HLCS displays a 
punctuate distribution pattern in chromatin despite lacking a strong DNA-binding 
domain. Previous studies suggest that the binding of HLCS to chromatin depends on 
DNA methylation. We tested the hypothesis that HLCS interacts physically with the 
DNA methyl transferase DNMT1 and the methyl CpG binding protein MeCP2 to 
facilitate the binding of HLCS to chromatin, and that these interactions contribute toward 
the repression of long terminal repeats (LTRs) by H3K9me marks. Co-
immunoprecipitation and limited proteolysis assays provided evidence suggesting that 
HLCS interacts physically with both DNMT1 and MeCP2. The abundance of H3K9me 
marks was 207% greater in the LTR15 locus in HLCS overexpression human embryonic 
kidney HEK293 cells compared with controls. This gain in H3K9me was inversely linked 
with a 87% decrease in mRNA coding for LTRs. Effects of HLCS abundance on LTR 
expression were abolished when DNA methylation marks were erased by treating cells 
with 5-azacytidine. We conclude that interactions between DNA methylation and HLCS 
are crucial for mediating gene repression by H3K9me, thereby providing evidence for 
epigenetic synergies between the protein biotin ligase HLCS and dietary methyl donors. 
Key words: Biotin; DNA methyl transferase; holocarboxylase synthase; methyl CpG 
binding protein 2; methylation; repression; long terminal repeats.
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Introduction 
HLCS is the sole protein biotin ligase in the human proteome (Suzuki et al., 1994) and 
has translational start sites in methionine-1, methionine-7, and methionine-58 (Hiratsuka 
et al., 1998). The classical role of HLCS is to catalyze the covalent binding of biotin to 
five distinct carboxylases in cytoplasm and mitochondria (Zempleni, Wijeratne, & 
Kuroishi, 2012). More recently, it became evident that HLCS also enters the cell nucleus 
(Bailey, Wallace, & Polyak, 2010; Bao, Wijeratne, Rodriguez-Melendez, & Zempleni, 
2011) where it binds to chromatin in a punctuate, locus-specific pattern (Camporeale, 
Giordano, Rendina, Zempleni, & Eissenberg, 2006; Singh, Pannier, & Zempleni, 2011). 
Unambiguous evidence suggests that recombinant HLCS catalyzes biotinylation of 
histone H3 in vitro and that HLCS knockdown causes a loss in histone H3 and H4 
biotinylation marks in vivo (Bao, Pestinger, et al., 2011; Chew et al., 2008; Pestinger, 
Wijeratne, Rodriguez-Melendez, & Zempleni, 2011; Rios-Avila, Pestinger, & Zempleni, 
2012). HLCS-dependent histone biotinylation marks are enriched in repressed genomic 
loci such as long terminal repeats (LTRs) suggesting a role of HLCS in gene repression 
(Camporeale, Oommen, Griffin, Sarath, & Zempleni, 2007; Chew et al., 2008; Pestinger 
et al., 2011; Rios-Avila et al., 2012; Wijeratne, Camporeale, & Zempleni, 2010). 
Biotinylation of histones H3 and H4 is a natural modification, but the abundance of 
biotinylation marks is too low (<0.001%) to account for the severe phenotypes seen in 
HLCS knockdown cells and flies (Bailey, Ivanov, Wallace, & Polyak, 2008; Kuroishi, 
Rios-Avila, Pestinger, Wijeratne, & Zempleni, 2011; Stanley, Griffin, & Zempleni, 
2001). These phenotypes include a de-repression of LTRs in human and murine cell lines 
and in Drosophila melanogaster, and short life span and low stress resistance in 
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Drosophila (Camporeale et al., 2006; Chew et al., 2008). Collectively, these observations 
point toward a role of HLCS in gene repression at the epigenetic level that is independent 
of histone biotinylation. 
We recently proposed that the roles of HLCS in gene repression are caused by 
interactions between HLCS and other chromatin proteins (Fig. 1) (Kuroishi et al., 2011). 
This theory integrates the discoveries described above with the following observations 
into a coherent model. First, HLCS binds to chromatin despite lacking a strong DNA-
binding domain (Camporeale et al., 2006; Singh et al., 2011). Second, two HLCS-binding 
proteins have been identified, namely histone H3 and the histone H3 lysine-9 
methyltransferase EHMT-1 (Bao, Pestinger, et al., 2011; Y. Li, Hassan, Moriyama, & 
Zempleni, 2013). Lysine-9 methylated histone H3 (H3K9me) is an abundant gene 
repression mark and EHMT-1 is one of the enzymes capable of creating this mark 
(Kouzarides & Berger, 2007). HLCS physically interacts with EHMT-1 and catalyzes the 
biotinylation of lysine (K) residues in EHMT-1, which strengthens the interactions 
between the proteins in vitro (Y. Li et al., 2013). Both biotin depletion and loss of HLCS 
cause a decrease of H3K9me marks (Chew et al., 2008; Gralla, Camporeale, & Zempleni, 
2008; Pestinger et al., 2011; Rios-Avila et al., 2012). Third, when DNA methylation 
marks are erased by 5-azacytidine treatment in human cell cultures, the abundance of 
histone biotinylation marks decreases considerably in LTRs; this is an uni-directional 
effect and biotin depletion has no effect on the abundance of DNA methylation marks 
(Chew et al., 2008). 
Here we tested the hypothesis that HLCS interacts with DNA methyltransferases 
(DNMT) and methyl-CpG-binding proteins (MeCPs), and that the binding of HLCS to 
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loci rich in methylated DNA increases the local abundance of H3K9me marks, thereby 
contributing toward the repression of LTRs. Our rationale for testing DNMT1, as 
opposed to DNMT3a and DNMT3b, was that the maintenance methyltransferase 
DNMT1 mediates DNA methylation in all somatic cells, whereas the de novo 
methyltransferases DNMT3a and DNMT3b mediate DNA methylation only in embryonic 
cells (E. Li & Bird, 2007; Schermelleh et al., 2007). However, DNMT3a and DNMT3b 
were tested as specificity controls. Our rationale for testing MeCP2, as opposed to other 
methylated DNA binding proteins such as MBD1, MBD2, and MBD4 (Bogdanovic & 
Veenstra, 2009; E. Li & Bird, 2007) was that MeCP2 binds exclusively to methylated 
DNA to cause gene repression, whereas MBD1 can bind to non-methylated DNA and 
MBD4 does not cause gene repression; also MeCP2 is more abundant and widely 
expressed compared to MBD1 (Bogdanovic & Veenstra, 2009; Kolker et al., 2012). Our 
rationale for assessing the effects of DNA methylation on HLCS-mediated and H3K9me-
dependent repression of LTRs, as opposed to other loci, was that DNA methylation, 
HLCS activity, biotin availability, and H3K9me have been implicated in LTR repression 
(Brenet et al., 2011; Chew et al., 2008; Martens et al., 2005; Pestinger et al., 2011). At 
least 54 LTRs in the human genome are transcriptionally active (Buzdin, Kovalskaya-
Alexandrova, Gogvadze, & Sverdlov, 2006), and pose a threat to genome stability, as 
their mobilization facilitates recombination between non-homologous loci, leading to 
chromosomal deletions and translocations (Kazazian, 2004; Martens et al., 2005). Drug-
induced hypomethylation of DNA is associated with activation of LTRs in mice 
(Jaenisch, Schnieke, & Harbers, 1985; Jahner et al., 1982; Stewart, Stuhlmann, Jahner, & 
Jaenisch, 1982) and with chromosomal instability and tumors (Eden, Gaudet, Waghmare, 
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& Jaenisch, 2003; Gaudet et al., 2003). Mobilization of LTR transposons is associated 
with 10% of all spontaneous mutations in mice (Waterston et al., 2002). Pericentromeric 
alpha satellite repeats on chromosomes 1 (Chr1alpha) and 4 (Chr4alpha) were tested as 
specificity controls because HLCS-dependent biotinylation events are implicated in their 
repression  (Camporeale et al., 2007). 
 
Results 
HLCS interacts with DNMT1 and MeCP2 
HLCS interacts physically with both DNMT1 and MeCP2, based on the following lines 
of evidence. Human embryonic kidney HEK293 cells were co-transfected with pCMV-
Myc-HLCS and pCMV-HA-DNMT1. When cell lysates were precipitated with anti-Myc 
and probed with anti-DNMT1, a distinct signal was obtained for DNMT1 (Fig. 2A, first 
lane). Likewise, when cell lysates were precipitated with anti-HA and probed with anti-
HLCS, a distinct signal was obtained for HLCS (Fig. 2B, first lane). When empty vectors 
(pCMV-Myc or pCMV-HA) were substituted for pCMV-Myc-HLCS and pCMV-HA-
DNMT1, respectively, no signals were obtained (negative controls, second lane in both 
gels). Overexpression of DNMT1 and HLCS was confirmed by probing whole cell 
extracts with anti-DNMT1 and anti-HLCS (input control, third and fourth lane in both 
gels). In contrast, no signal was obtained when HEK293 cells were co-transfected with 
pCMV-Myc-HLCS and pCMV-HA-DNMT3a or pCMV-HA-DNMT3b, followed by 
probing anti-Myc precipitates with anti-HA, or when anti-HA precipitates were probed 
with anti HLCS (specificity control, data not shown). 
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Similar experiments were conducted for MeCP2. HEK293 cells were co-transfected with 
pCMV-Myc-HLCS and pCMV-HA-MeCP2. When cell lysates were precipitated with 
anti-Myc and probed with anti-MeCP2, a distinct signal was obtained for MeCP2 (Fig. 
2C, first lane). Likewise, when cell lysates were precipitated with anti-HA and probed 
with anti-Myc, a distinct signal was obtained for HLCS (Fig. 2D, first lane). When empty 
vectors (pCMV-Myc or pCMV-HA) were substituted for pCMV-Myc-HLCS and pCMV-
HA-MeCP2, respectively, no signals were obtained (second lane in both gels). 
Overexpression of MeCP2 and HLCS was confirmed by probing whole cell extracts with 
anti-MeCP2 and anti-Myc (input control, third and fourth lane in both gels). 
Next, limited proteolysis assays were conducted using recombinant HLCS, DNMT1, and 
MeCP2. Limited proteolysis assays are based on the principle that physical interactions 
between proteins delay their degradation by dilute solutions of proteases such as trypsin 
(Chazin, 2007). When His-tagged DNMT1 was mixed with GST-tagged HLCS prior to 
treatment with trypsin, the proteolytic digestion of DNMT1 and HLCS was slow, as 
evidenced by staining gels with blue stain (Fig. 3A, left panel). Meaningful amounts of 
protein were detected even after 90 min of incubation with trypsin. In contrast, when 
DNMT1 was incubated with GST tag alone, DNMT1 was degraded within less than 5 
min, and GST started to degrade within 5 min of incubation (Fig. 3A, right panel). 
Likewise, when His-tagged MeCP2 was mixed with GST-tagged HLCS prior to 
treatment with trypsin, the proteolytic digestion of HLCS and MeCP2 was slow. 
Meaningful amounts of protein were detected even after 45 min of incubation with 
trypsin. (Fig. 3B, left panel). In contrast, when MeCP2 was incubated with GST tag 
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alone, both MeCP2 and GST were degraded within 10 to 30 min of incubation (Fig. 3B, 
right panel). 
Synergies between DNA methylation events and HLCS in the repression of LTRs 
Our central hypothesis is that DNMT1 and MeCP2 facilitate the binding of HLCS to 
distinct loci in chromatin, and that HLCS recruits the histone methyltransferase EHMT-1 
to repress genes through creating H3K9me marks. This hypothesis is partly based on 
previous observations suggesting that HLCS knockdown causes a loss of H3K9me mark 
in LTRs (Chew et al., 2008). Here we substantiated these previous observations by 
conducting HLCS overexpression experiments. HLCS was stably overexpressed in 
HEK293 cells. The abundance of mRNA coding for HLCS was 69±4.6 times greater in 
overexpression cells compared with non-transfected controls; values were normalized by 
the abundance of mRNA coding for glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). The differences were similar when HLCS was probed with anti-HLCS or anti-
Myc in western blots (Fig. 4). 
Consistent with our central hypothesis, HLCS overexpression caused a 207% increase of 
H3K9me marks in the LTR15 locus in HEK293 cell compared with non-transfected 
controls (Fig. 5A). A similar HLCS-dependent increase (33%) of H3K9me marks was 
also seen in the LTR22 locus but the difference was not statistically different between 
HLCS overexpression cells and controls. The HLCS-dependent enrichment of H3K9me 
marks was not specific for LTRs but was also seen in Chr1alpha and Chr4alpha repeats 
(Fig. 5A). In contrast, HLCS overexpression had no effect on the enrichment of H3K9me 
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marks in promoter of GAPDH gene in euchromatin and the promoter of the 
transcriptionally repressed, colon-specific Apobec1 gene. 
The HLCS-dependent enrichment of H3K9me marks in LTRs caused an 87% decrease in 
the abundance of mRNA coding for LTRs (Fig. 5B). Importantly, this effect was 
abrogated when DNA methylation marks were erased by treating HEK-293 cells with 5-
azacytidine. Note that transcripts coding for distinct LTRs are nearly identical and cannot 
be distinguished by regular quantitative real-time PCR. Therefore the mRNA values 
reported for LTRs represents the global expression of LTRs, as opposed to representing 
individual LTRs. Also note that LTRs may produce two distinct transcripts, U5 and R-
U5, and that both transcripts depended on HLCS expression and DNA methylation. 
Again, effects of HLCS overexpression and 5-azacytidine treatment on transcriptional 
activity were not specific for LTRs, but were also seen in Chr1alpha and Chr4alpha 
repeats (Fig. 5B). 
 
Discussion 
This is the first report offering a potential mechanism for recruiting HLCS to distinct loci 
in chromatin. Based on this report, physical interactions between HLCS and DNMT1 and 
MeCP2 contribute toward the positioning of HLCS in human chromatin. This observation 
goes beyond our previous studies, which suggest that HLCS interacts physically with the 
core histones H3 and H4 and the histone methyltransferase EHMT-1 (Bao, Pestinger, et 
al., 2011; Y. Li et al., 2013). The interactions between HLCS and histones may account 
for the binding of HLCS to chromatin, but does not explain the punctuate pattern of 
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HLCS localization that was observed in previous studies (Camporeale et al., 2006; Singh 
et al., 2011), simply because core histones can be found in all nucleosomes in chromatin. 
Likewise, the interactions between HLCS and EHMT-1 are unlikely to mediate the initial 
positioning of HLCS, based on previous observations that HLCS knockdown causes a 
loss of EHMT-1 dependent H3K9me marks (Chew et al., 2008; Gralla et al., 2008; 
Pestinger et al., 2011). This study provides compelling evidence that HLCS interacts 
physically with DNMT1 and MeCP2 and that DNA methylation marks are important for 
subsequent HLCS/EHMT-1 interactions leading to the creation of H3K9me marks. 
This paper is also the first report to identify epigenetic synergies between dietary methyl 
donors such as folate, methionine and choline, which are essential one-carbon donors in 
DNA and histone methylation events (Stover, 2009; Wolff, Kodell, Moore, & Cooney, 
1998; Zeisel, 2009), and the micronutrient biotin, which appears to be essential for the 
creation of H3K9me marks (Chew et al., 2008; Gralla et al., 2008; Pestinger et al., 2011). 
It remains to be determined whether methyl donors and biotin can compensate for each 
other’s deficiency or whether the deficiency of one of the two can precipitate the other’s 
deficiency symptoms. We do not propose that biotinylation of histones per se contributes 
in quantitatively meaningful ways to gene repression, because histone biotinylation 
marks are too rare to elicit such effects (Bailey et al., 2008; Kuroishi et al., 2011; Stanley 
et al., 2001). 
Our model that HLCS is member of a multiprotein gene repression complex is more 
complicated than shown in Figure 1. For example, we have developed an algorithm to 
predict HLCS-interacting proteins and that algorithm identified not only EHMT-1 but 
also the nuclear co-repressor N-CoR2 as an HLCS interacting protein (Y. Li et al., 2013). 
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N-CoR participates in the recruitment of histone deacetylases to human chromatin (Wen 
et al., 2000). Histone deacetylases catalyze the removal of acetylation marks from 
histones, thereby causing gene repression (Wang et al., 2009). Ongoing studies in our 
laboratory suggest that HLCS interacts physically with both N-CoR and histone 
deacetylases (D. Liu and J. Zempleni, unpublished). Depending on the outcome of these 
studies, the model shown in Figure 1 will need to be amended in the future.  
The chromatin HLCS/multiprotein complex constitutes a plausible machinery 
contributing toward transcriptional repression of LTRs. Transcriptionally competent 
LTRs are enriched with H3K9me3 marks and the CpGs located in LTRs are generally 
hypermethylated (Meissner et al., 2008; Mikkelsen et al., 2007). Evidence suggests that 
LTRs are also docking sites for HLCS, judged by the local enrichment of HLCS-
dependent biotinylation marks (Chew et al., 2008). Both LTR15 and LTR22 are 
transcriptionally active and were chosen as representative examples of abundant 3’ 
proviral and solitary LTRs respectively, in the human genome (Buzdin et al., 2006). 
Considering the importance of repressing LTRs for maintaining genome stability, this 
paper may have implications for methyl/biotin and HLCS/protein synergies in gene 
regulation and disease risk. Importantly, our studies suggest that these synergies are not 
limited to the repression of LTRs, but also play roles in the repression of other repeats 
including pericentromeric alpha satellite repeats. 
Some uncertainties remain. One might ask why HLCS participates in the creation of 
repression marks in the LTR15 locus, but to a much small extent in the LTR22 locus, and 
at non-detectable levels in the Apobec1 locus. A possible explanation could be that 
LTR15 is a proviral LTR, whereas LTR22 is a solitary LTR (Buzdin et al., 2006). 
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Redundancies among histone K9-methyltransferases might also contribute to site 
specificity. The human genome encodes for H3K9 methyltransferases other than EHMT-
1, e.g., SETDB1 and ESET (Schultz, Ayyanathan, Negorev, Maul, & Rauscher, 2002; 
Yang et al., 2002). Histone methyltransferases other than EHMT-1 might not interact 
with HLCS. This issue will need to be addressed in future studies demonstrating co-
localization of HCS and EHMT-1 in the same loci by using chromatin 
immunoprecipitation studies, or by using transgenic cell lines in which histone 
methyltransferases other than EHMT-1 have been knocked down. Likewise, methyl-
CpG-binding proteins other than MeCP2 may have distinct effects in regard to recruiting 
HLCS to target loci. The absence of effect in the Apobec1 locus might be due to the fact 
that HLCS containing multiprotein complexes specifically target repeat regions such as 
LTRs and pericentromeric alpha satellite repeats, but that is untested speculation. 
We conclude that HLCS exerts some of its roles in gene regulation through the formation 
of multiprotein gene repression complexes in human chromatin. Possible members of this 
complex include proteins involved in DNA methylation, EHMT-1, N-CoR2, and histone 
deacetylases. This theory would integrate previous observations that HLCS and biotin are 
important for gene repression, the low abundance of biotinylated histones in chromatin, 
and the known roles of members of the putative multiprotein complex in mediating gene 
repression into a coherent model. 
 
Materials and Methods 
Plasmids 
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Full-length human HLCS (NM_000411) was subcloned from plasmid pET41a (+)- 
HLCS (Esaki, Malkaram, & Zempleni, 2012) into vector p3XFLAG-CMV-26 (Sigma-
Aldrich, Cat# E7283) using NotI and XbaI, thereby creating plasmid FLAG/Myc-HLCS 
for studies of HLCS overexpression and its effects on H3K9me marks and LTR 
transcriptional activity. Plasmid pCMV-myc-HLCS was created as described previously 
(Y. Li et al., 2013) and was used for overexpression of Myc-tagged HLCS in co-
immunoprecipitation studies. Full-length human MeCP2 (Genbank 
Accession:NM_004992) was subcloned from plasmid pGADT7-MeCP2 (unpublished) 
into vector pCMV-HA (Clontech, Cat# 635690) using Sfil and XhoI for overexpression of 
HA-tagged MeCP2. Full-length DNMT1 (Genbank Accession:NM_001130823.1) was 
subcloned from pBluescript SK (+)- DNMT1 (unpublished) into pCMV-HA vector using 
NdeI and SalI for overexpression of HA-tagged DNMT1. Plasmid pET41a (+)-HLCS 
was used to prepare GST-tagged recombinant full-length HLCS as described previously 
(Bao, Pestinger, et al., 2011). Full-length MeCP2 was subcloned from plasmid pET41a 
(+)-MeCP2 (unpublished) into vector pET28a+ (Novagen, Cat# 698646) using EcoRI and 
XhoI (creating pET28a-MeCP2), and full-length DNMT1 was subcloned from pET41a 
(+)-DNMT1 (unpublished) into pET28a+ vector using EcoRI and SalI (creating pET28a-
DNMT1) for the preparation of recombinant proteins. As specificity controls, full-length 
human DNMT3a and DNMT3b were subcloned from plasmids pCMV-sport6-DNMT3A 
(Invitrogen, cat#6150112) and pENTR223.1-DNMT3B (Invitrogen, cat#40080762) into 
vector pCMV-HA using EcoRI and SalI to create plasmids pCMV-HA-DNMT3a and 
pCMV-HA-DNMT3b, respectively, for overexpression of HA-tagged DNMT3a and 
DNMT3b. The identities of all plasmids were verified by sequencing. 
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Cell lines 
Human embryonic kidney HEK293 cells (American Type Culture Collection, CRL-1573) 
were cultured following the vendor’s recommendations. Cells were transfected with 
plasmid FLAG/Myc-HLCS by using electroporation and the transfectants were selected 
using 1 mM G418 for 14 days, and maintained in medium containing 0.4 mM G418. The 
expression of HLCS and GAPDH (control) was assessed by quantitative real-time PCR 
(qRT-PCR; see below) and by western blot analysis using anti-Myc (Abcam, cat# 
ab9106) and anti-HLCS serum (Chew, Camporeale, Kothapalli, Sarath, & Zempleni, 
2006). For co-immunoprecipitation assays, HLCS, DNMT1 and MeCP2 were transiently 
overexpressed as described below. 
Co-immunoprecipitation assays 
HEK293 cells were seeded in 25-cm
2
 flasks (2.5 x 10
6
 cells/flask) 24 h before transient 
transfection with 8 μg of plasmids (4 µg each for Myc- and HA-tagged proteins) in 
TurboFect reagent (Fermentas, Cat# R0531) and Opti-MEM I medium (Invitrogen, Cat# 
31985). Cells from six flasks were collected 48 h after transfection  and lysed in 20 mM 
Tris HCl buffer (pH 8.0), containing 137 mM NaCl, 10% glycerol, 1% CA-630, 2 mM 
EDTA, phenylmethylsulfonyl fluoride, and protease inhibitor cocktail (Sigma-Aldrich, 
Cat# P2714). Samples were pre-cleared using rabbit IgG before precipitation of proteins 
with rabbit polyclonal anti-HA (Abcam, Cat# ab9110), anti-Myc (Abcam, Cat# ab9106), 
and protein A resin (Thermo Scientific, Cat#20338). Western blots were performed using 
anti-MeCP2 (Abcam, Cat# ab2028), anti-DNMT1 (Abcam, Cat# ab16632), anti-Myc, 
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anti-HLCS(Chew et al., 2006) and appropriate fluorophore conjugated secondary 
antibodies (Pestinger et al., 2011).  
Limited-proteolysis assays 
Recombinant proteins were overexpressed in ArcticExpress (DE3) E. coli and purified 
using a Glutathione resin (Genscript, Cat# L00206) or a HisTrap FF column (GE 
Healthcare, Cat# 17-5319-01) as described previously (Bao, Pestinger, et al., 2011). 
Limited proteolysis was performed at 37°C in 75 mM Tris acetate buffer (pH 7.5), 
containing 0.3 mM dithiothreitol and 45 mM MgCl2. One aliquot (time-zero sample) was 
collected before adding trypsin (Sigma-Aldrich, Cat# T6567), and equal volumes of 
aliquots were collected at timed intervals after initiation of digestion. Proteins were 
separated by gel electrophoresis and stained using Coomassie blue (Y. Li et al., 2013). In 
control experiments MeCP2 and DNMT1 were incubated with GST peptide to formally 
eliminate the possibility that the GST tag protected the proteins against proteolytic 
digestion. 
5-Azacytidine treatment 
5-Azacytidine solutions were prepared freshly immediately prior to use. Pilot tests 
suggested that 1 μM 5-azacytidine does not affect HEK293 cell viability. HEK293 cells 
were seeded in T25 flasks in fresh growth medium at day 0, and 5-azacytidine was added 
on day 1 to produce a final concentration of 1 μM. Media were changed daily 
maintaining the concentration of 5-azacytidine at 1 μM. On day 5, the cells were washed 
with phosphate-buffered saline and collected for analysis of gene expression by qRT-
PCR. 
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Micro chromatin immunoprecipitation assay 
The enrichment of H3K9me in distinct loci in human chromatin was assessed by micro 
chromatin immunoprecipitation (μChIP) assay as described before, using 2.5 x 106 
HEK293 cells (Dahl & Collas, 2008; Pestinger et al., 2011). ChIP-grade anti-H3K9me 
was purchased from Abcam (ab8898). Quantification of amplicons, calculation of relative 
enrichment of histone marks and normalization of nucleosomal occupancy using 
(nonmodified) C-terminus in histone H3 (Abcam, Cat# ab1791) were conducted as 
described previously (Chew et al., 2008; Rios-Avila et al., 2012). Data are expressed as 
percent of input DNA. 
qRT-PCR 
Power SYBR Green PCR Master Mix (Applied Biosystems, Cat# 4309155) was used to 
quantify the abundance of transcripts by qRT-PCR. Perfecta SYBR Green FastMix 
(Quanta Biosciences, Cat# 95073) was used to quantify the abundance of amplicons in 
immunoprecipitated chromatin (Pestinger et al., 2011). PCR primers are listed in Table 1. 
Pericentromeric alpha satellite repeats are repressed through HLCS- and methylation-
dependent epigenetic events and were used as specificity controls (Camporeale et al., 
2007; Martens et al., 2005). Apobec1 is specifically expressed in colon and its expression 
is silenced in kidney tissues as confirmed by searching against the BioGPS database (Wu 
et al., 2009). 
Statistical analysis 
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Data from μChIP assays were tested for normality of distribution and homogeneity of 
variances by constructing the probability plot of the residues, the stem-and-leaf plot of 
the residuals, and the normal probability plot and performing the Shapiro-Wilk test (SAS, 
2008). using the SAS 9.2 software package (SAS Institute, USA). After log 
transformation, the data were still not normally distributed and, therefore, were analyzed 
by the Kruskal-Wallis test as a robust substitute for one-way Anova (McDonald, 2009). 
Calculations are based on five repeats. Differences were considered statistically 
significant if p-value was <.01. The data for quantification of LTR transcripts were 
analyzed by student’s t-test. Calculations were based on three repeats. Differences were 
considered statistically significant if p-value was <.05. Data are expressed as mean±S.D. 
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Table 1. PCR primers 
Target Sequence F/R
a
 Template
b
 
Apobec1 5’-TCCCATAACTGCCTGAGATG-3’ F DNA 
 5’-TTGTTCCTGGACTTTGTTGC-3’ R DNA 
Chr1alpha 5’-TCATTCCCACAAACTGCGTTG-3’ F DNA/Transcript 
 5’-TCCAACGAAGGCCACAAGA-3’ R DNA/Transcript    
Chr4alpha 5’-CTGCACTACCTGAAGAGGAC-3’ F DNA/Transcript 
 5’-GATGGTTCAACACTCTTACA-3’ R DNA/Transcript    
GAPDH 5’-CGTAGCTCAGGCCTCAAGA-3’ F DNA 
 5’-GCTGCGGGCTCAATTTATAG-3’ R DNA 
GAPDH 5’-TCCACTGGCGTCTTCACC-3’ F Transcript 
 5’-GGCAGAGATGATGACCCTTT-3’ R Transcript 
HLCS 5’-TGAGACCTGATCCTTAACTTCC-3’ F Transcript 
 5’-ATGGAAGATAGACTCCACAT-3’ R Transcript    
LTR15 5’-TTGTCATTGGTTCTGTGTAGGG-3’ F DNA 
 5’-CCTCCATATGCTGAACGCTG-3’ R DNA 
LTR22 5’- GACCATTTGCATGGACAAATC-3’ F DNA 
 5’- CCTCCATATGCTGAACGCTG-3’ R DNA 
LTR, R-U5 5’-GCGGGCAGCAATACTGCTTTGTAA-3’ F Transcript   
 5’-ACCAGCGTTCAGCATATGGAGGAT-3’ R Transcript 
LTR, U5 5’-AACTCAGAGGCTGGCG-3’ F Transcript 
 5’-AGACACAGAGACAAAGTATAGAGA-3’ R Transcript 
Apobec1= apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 (Genbank 
NC_000012.11); Chr1alpha= chromosome 1 alpha satellite repeats (GenBank M26919); 
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Chr4alpha= chromosome 4 alpha satellite repeats (GenBank M38467); GAPDH= 
glyceraldehyde-3-phosphate dehydrogenase (GenBank NG_007073.2 for genomic DNA, 
NM_002046.4 for transcript); HLCS= Holocarboxylase Synthetase (GenBank 
NM_000411.6); LTR15= intact LTR (GenBank AC116309) (Buzdin et al., 2006); 
LTR22= solitary LTR (GenBank AL451165) (Buzdin et al., 2006); LTR, R-U5= region 
between R and U5 of LTR of HERV-K families (Kovalskaya, Buzdin, Gogvadze, 
Vinogradova, & Sverdlov, 2006); LTR, U5= U5 region of LTR of HERV-K families 
(Kovalskaya et al., 2006). 
a
F= Forward; R= Reverse. 
b
DNA, genomic DNA for ChIP assay; Transcript, cDNA for qRT-PCR.  
  
38 
 
Figure and legends 
Figure 1. HLCS facilitates methylation events in the epigenome through physical 
interactions with DNA methyltransferase 1 (DNMT1), methyl CpG binding protein 2 
(MeCP2), and eukaryotic histone methyltransferase (EHMT-1). 
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Figure 2. HLCS interacts with both MeCP2 and DNMT1 in vivo, judged by co-
immunoprecipitation assay. Myc-HLCS and HA-DNMT1 were overexpressed in 
HEK293 cells and protein extracts were immunoprecipitated using anti-Myc (panel A) 
and anti-HA (panel B). Proteins were resolved by electrophoresis and probed with anti-
DNMT1 (panel A) and anti-HLCS (panel B). Panels C and D are similar to A and B, but 
HA-MeCP2 was substituted for HA-DNMT1 in overexpression experiments and anti-
MeCP2 (panel C) and anti-Myc (panel D) were substituted for anti-DNMT1 and anti-
HLCS, respectively. Transfections with empty vectors were used as negative controls 
(second lane in each gel), and whole cell lysates were used as input controls (third and 
fourth lane in each gel). Gels were electronically re-arranged to facilitate comparisons. 
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Figure 3. HLCS interacts with both MeCP2 and DNMT1 in vitro, judged by limited 
proteolysis assay. (A) Purified recombinant GST-HLCS protected His-DNMT1 from 
trypsin digestion (left panel) compared with DNMT1 that was pre-incubated with GST 
(right panel). (B) Purified recombinant GST-HLCS protected His-MeCP2 from trypsin 
digestion (left panel) compared with MeCP2 that was pre-incubated with GST (right 
panel). 
 
Figure 4. Transfection with plasmid FLAG/Myc-HLCS produced a stable overexpression 
of HLCS compared with non-transfected controls. The Myc-tagged HLCS in cell extracts 
was probed with anti-HLCS and anti-Myc. GAPDH was probed as loading control. 
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Figure 5. The effects of HLCS on LTR repression depend on DNA methylation. (A) The 
enrichment of H3K9me3 marks in loci coding for LTR15, Chr1alpha, Chr4alpha, 
GAPDH, and Apobec1 was quantified by chromatin immunoprecipitation assay/qRT-
PCR in HEK293 HLCS overexpression cells and control cells (H=6.9018, 1 d.f., *p-
value=0.0086 HLCS overexpression vs. control, H=4.8402, 1 d.f., *p-value=0.0278 for 
Chr1alpha, H=6.8598, 1 d.f., p-value=0.0088 for Chr4alpha, H=0.1756, 1 d.f., p-
value=0.6752 for GAPDH, and H=0.7245, 1 d.f., p-value=0.3947 for Apobec1). (B) The 
transcription of LTRs, Chr1alpha, and Chr4alpha was repressed in HLCS overexpression 
HEK293 cells compared with controls. Treatment of 5-azacytidine (1 µM) abrogated the 
effects of HLCS on repeat repression (**p-value<0.0001, *p-value<0.05, 5-azacytidine 
treatment vs. control).  
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Abstract 
In a recent mass spectrometry screen we have identified 108 new proteins that were 
modified endogenously by covalent binding of biotin; members of the heat shock 
superfamily of proteins, including heat shock protein 72 (HSP72), were overrepresented 
among the biotinylated proteins. Mammals respond to infections by secreting 
extracellular HSP72 (eHSP72) which elicits an immune response. Here, we identified 
five biotinylation sites in HSP72 using mass spectrometry and site-directed mutagenesis. 
We used co-immunoprecipitation, mass spectrometry, and limited proteolysis assays to 
demonstrate that HSP72 interacts physically with the protein biotin ligase, 
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holocarboxylase synthetase (HLCS) leading to the biotinylation of residues K112, K128 
K348, K361, K415, and probably additional lysines. Finally, we demonstrated that 
HLCS-dependent biotinylation of eHSP72 increases the expression of the chemokine 
RANTES by the HEK293 human embryonic kidney cells. In conclusion, we report a 
novel endogenous modification of HSP72 and demonstrated that the binding of biotin to 
eHSP72 poises cells for a strong immune response. 
Key words: Biotin; heat shock protein 72; holocarboxylase synthetase; posttranslational 
modification; RANTES. 
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Introduction 
The stress-inducible heat shock protein 72 kDa (HSP72) localizes in cytoplasm, nucleus 
and extracellular space, and is essential for the cellular response to the accumulation of 
unfolded protein and immune function (Asea, 2005; Mambula, Stevenson, Ogawa, & 
Calderwood, 2007). HSP72 is released from cell through passive and active pathways 
(Mambula et al., 2007, Asea, 2005 #8472). The level of extracellular HSP72 (eHSP72) 
increased in response to bacterial infection in rats (Campisi, Leem, & Fleshner, 2003), 
treatment with lipopolysaccharides in THP-1 human monocytic cells (Abboud et al., 
2008), and inhibition of phospholipase C in A431 human squamous carcinoma cells 
(Evdonin et al., 2009). Unlike intracellular HSP72, eHSP72 promotes the secretion of 
proinflammatory cytokines, mediated by binding to cell surface receptors (Asea et al., 
2000; Campisi et al., 2003; Multhoff et al., 1999). Covalent binding of the vitamin biotin 
to eHSP72 (eHSP72bio), accomplished by synthetic cross linkers and recombinant 
HSP72, increases the binding eHSP72 to its receptors on the cell surface, thereby 
enhancing the secretion of the chemokine RANTES in cell cultures (Tao, Nishikawa, 
Nomura, Kitabatake, & Tani, 2005). 
Recently, we discovered 108 novel biotinylated proteins in a human kidney cell line (Li 
Y. et al., in preparation). Molecular chaperones, including HSP72, were overrepresented 
among biotinylated proteins and accounted for 17% of the novel targets for biotinylation. 
Presumably, the binding of the vitamin biotin to HSPs is catalyzed by the sole protein 
biotin ligase in the human genome, holocarboxylase synthetase (HLCS) (Suzuki et al., 
1994). Considering the importance of eHSP72bio in RANTES signaling and the 
biological significance of RANTES in the chemoattraction and activation of a wide 
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variety of immune cells during immune response (Krensky & Ahn, 2007), we (i) 
determined whether HLCS interacts with HSP72 to catalyze its biotinylation, (ii) 
identified biotinylation sites in HSP72, and (iii) determined whether HLCS-dependent 
biotinylation of HSP72 increases the expression of RANTES. 
 
Results 
HSP72 interacts physically with HLCS 
Whole cell lysates from HEK293 cells overexpressing HLCS were precipitated with anti-
Myc and probed with anti-HSP72 and anti-Myc in western blots. Distinct bands for 
HSP72 and HLCS were observed in HLCS overexpression cells; only a faint HSP72 band 
and no HLCS band were detected in untransfected controls (Fig. 1A). The abundance of 
HSP72 in input samples was the same for HLCS overexpression cells and controls.  
Next, whole cell lysates were precipitated with anti-Flag and resolved by gel 
electrophoresis. A distinct band with an apparent mass of 72 kDa was visible after blue 
staining (Fig. 1B) and was identified as HSP72 using LC/MS/MS and Mascot 
(probability score= 242) (Perkins, Pappin, Creasy, & Cottrell, 1999). 
Overexpression of HLCS did not cause cell stress in Flag-Myc-HLCS cells, judged by the 
expression of HSP72. The abundance of HSP72 protein was not affected by HLCS 
overexpression (Fig. 2A). The abundance of HSP72 mRNA was only moderately 
increased (~50%) in HLCS overexpression cells compared with controls (Fig. 2B). 
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Transcripts from both HSPA1A and HSPA1B contributed to the moderate increase in 
HSP72 mRNA (Fig. 2C). 
The physical interaction between HLCS and HSP72 was confirmed using limited 
proteolysis assays. Pre-incubation of His-HSP72 with GST-HLCS protected HSP72 
against proteolysis when compared with GST tag as negative control (Fig. 3). 
HLCS-dependent biotinylation of HSP72 
HLCS has HSP72 biotin ligase activity. When GST-HLCS was incubated with His-
HSP72, biotin, and co-factors at 37°C for 2 hours, covalent binding of biotin to HSP72 
was evident, as judged by streptavidin gel electrophoresis; GST served as negative 
control (Fig. 4A).  
HSP72 is also a target for biotinylation in vivo. Biotinylated proteins were purified from 
HEK293 whole cell lysates using avidin column and analyzed by LC/MS/MS. Seven 
independent samples were assayed in separate analytical runs, and consistently produced 
a biotinylation signal for HSP72. As expected for HLCS-dependent biotinylation, lysine 
residues were the only biotinylation sites detected. Five biotinylation sites were identified: 
K112, K128 K348, K361 and K415 (Fig. 4B). The Mascot probability scores for HSP72 
were 1067, 808, 3848, 440, 11447, 108 and 2965. 
Impact of individual lysine residues on HSP72 biotinylation and interaction with 
HLCS 
The following mutants were created: (i) HSP72K112,128R with lysines 112 and 128 mutated 
to arginines; (ii) HSP72K348,361,415R with lysines 348, 361, and 415 mutated to arginines; 
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and (iii) HSP72K112-415R with all five lysines mutated. None of the mutated residues is 
highly conserved in HSP72, based on the profile Hidden Markov Model (pHMM) 
(Sonnhammer, Eddy, & Durbin, 1997) (Fig. 5A). In pHMM, the height of the stack of 
letters at each position represents its information content, which measures the 
conservation of a position in a profile (Schuster-Bockler, Schultz, & Rahmann, 2004). All 
three HSP72 mutants interacted physically with HLCS and were substrates for 
biotinylation by HLCS (Fig. 5B), suggesting that lysines other than the five residues 
identified by LC/MS/MS are also targets for biotinylation, at least in vitro (see 
Discussion and Materials and methods). 
HLCS-mediated biotinylation on HSP72 stimulate RANTES production 
Biotinylated HSP elicits an increase in the expression of RANTES in HEK293 cells. 
Recombinant HSP72 and HSP72K112-415R were biotinylated using recombinant HLCS. 
When biotinylated HSP72 was added to cell culture media, the expression of RANTES 
mRNA increased significantly at HSP72 levels of ≥0.5 μM compared with HSP72 
prepared in the absence of HLCS (Fig. 6A). When HLCS was added to the cell cultures, 
RANTES mRNA levels increased suggesting that eHSP72 might have been biotinylated 
by exogenous HLCS. The addition of biotinylated HSP72K112-415R to culture media also 
caused an increase in RANTES expression (Fig. 6B), consistent with the theory that 
lysines other than the five residues identified by LC/MS/MS are also targets for 
biotinylation. Biotinylated HSP72K112-415R caused an increase in RANTES mRNA at 
concentrations as low as 0.1 μM.  
 
52 
 
 
 
Discussion 
This is the first report of a novel biotinylated protein in the human proteome, HSP72. 
This discovery is biologically important from the following points of view. First, we 
recently identified 108 novel proteins that are targets for biotinylation in vivo (Li Y. et al., 
in preparation). Here we show that the covalent binding of biotin is of biological 
significance for at least some of these proteins. Second, heat shock proteins like HSP72 
play essential roles in protein processing and transport and in stress and immune response 
(Asea, 2005; Bukau & Horwich, 1998; Hartl, 1996; Mambula et al., 2007). One can 
assume with a reasonable level of confidence that posttranslational modifications that 
affect the activities of these proteins will have meaningful effects in cellular metabolism. 
The biotinylation of HSP72 was of particular interest in our follow-up studies for the 
mass spectrometry screen, based on the rationale that biotinylated HSP72 was detected in 
every single cell extract and mass spectrometry experiment that we conducted. In 
addition, HSP72 is unique in that it is secreted into the extracellular space where it binds 
to receptors on the cell surface to increase the expression and secretion of the chemokine 
RANTES (Krensky & Ahn, 2007), thereby enhancing the immune response (Campisi et 
al., 2003). Note that a recent report suggests that chemical, not site-specific biotinylation 
of eHSP72 increases the secretion of RANTES by HEK293 cells (Tao et al., 2005), 
consistent with our observations using enzymatic, site-specific biotinylation of lysine 
residues. The increased binding of biotinylated HSP72 to cell surface receptors compared 
with non-biotinylated HSP72 may be caused by an increase in the hydrophobicity of 
proteins due to the biotin mark (Storm, Loos, & Kaul, 1996), but these lines of 
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interpretations are controversial (Tao et al., 2005) and biotin might have a more specific 
effect. 
A few uncertainties remain and will need to be addressed in future studies. For example, 
it is unknown whether a person’s biotin status affects the abundance of HSP72 
biotinylation marks. Evidence suggests that biotinylated proteins such as carboxylases 
rapidly lose the coenzyme biotin in biotin-depleted cell cultures and persons (Eng et al., 
2013; Kaur Mall, Chew, & Zempleni, 2010). Our studies using the HSP72K112-415R mutant 
suggest the existence of additional biotinylation sites, but these sites escaped detection in 
our mass spectrometry analysis. We speculate that biotinylation marks in these sites are 
rare and might be less important than the five sites identified in this study. 
In conclusion, we provide evidence that the number of biotinylated proteins in the human 
proteome is substantially larger than previously thought, and we posit that some of these 
biotinylation marks affect protein function, including stress response systems. 
 
Methods and Materials 
Cell lines 
Human embryonic kidney HEK293 cells (American Type Culture Collection, CRL-1573) 
were cultured following the vendor’s recommendations. Cells overexpressing Flag- and 
Myc-tagged HLCS were created as described previously (Xue, Wijeratne, & Zempleni, 
2013).  
Plasmids and recombinant proteins 
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Plasmid pET41a (+)-HLCS was used to prepare GST-tagged recombinant full-length 
HLCS as described previously (Bao et al., 2011). Full-length human HSP72 (NCBI 
accession NM_005345.5) was cloned from HEK293 cell cDNA prepared using forward 
primer 5’-GTCCGAATTCGGGGCCAAAGCCGCGGCGATCGGCATCGA-3’ and 
reverse primer 5’- GGACCTCGAGCATCTACCTCCTCAATGGTGGGGCCTGACCC-
3’. The PCR product was digested and ligated into vector pET28a+ (Novagen) using 
EcoRI and XhoI to create pET28a+_HSP72. Recombinant HSP72 was expressed in E. 
coli and purified as described previously (Bao et al., 2011), including the removal of 
recombinant HSP72 that was biotinylated by BirA in E. coli (Kobza, Sarath, & Zempleni, 
2008). HSP72 mutants were created by site-directed mutagenesis, using plasmid 
pET28a+_HSP72 and the Geneart Site-Directed Mutagenesis kit (Invitrogen). The 
identities of all plasmids were verified by sequencing. 
Co-immunoprecipitation assay 
Co-immunoprecipitation assays were conducted in HEK293 cells overexpressing Flag- 
and Myc-tagged HLCS as described previously (Li, Hassan, Moriyama, & Zempleni, 
2013) except that the cells were pre-treated with 0.125 M formaldehyde at room 
temperature for 15 min, followed by quenching with 0.125 M glycine. Proteins were 
resolved using 4-12% Bis-Tris gels, using untranfected HEK293 cells as negative 
controls. The gels were blue stained for analysis by mass spectrometry or probed with 
anti-HSP72 (Enzo Life Sciences) and anti-Myc (Abcam). 
Limited proteolysis assay 
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Limited proteolysis was performed by incubating His-tagged HSP72 or indicated mutants 
with GST-tagged HLCS or GST tag at 37°C as described previously (Li et al., 2013).    
Semi-quantitative PCR and quantitative real-time PCR (qRT-PCR) 
The HSP72 monomer is encoded by two distinct genes, HSPA1A and HSPA1B with 5nt 
difference in their coding sequences (Milner & Campbell, 1990). cDNA was prepared 
from HEK293 cells overexpressing HLCS and untransfected controls. Semi-quantitative 
PCR was performed using the following primers: HSPA1A transcript was amplified 
using the primers specified above; for HSPA1B transcripts the reverse primer was 
changed to 5’-GGACCTCGAGCATCCACCTCCTCAATGGTAGGGCCTGACCCAG-
3’. Beta-actin (forward; 5’-GCACAGAGCCTCGCCTTTGCC-3’; reverse: 5’-
CGGCCAGAGGCGTACAGGGA-3’) and GAPDH (forward: 5’-
GGTCGTATTGGGCGCCTGGT-3’; reverse: 5’-ACAGTTTCCCGGAGGGGCCA-3’) 
were used as controls. Power SYBR Green PCR Master Mix (Applied Biosystems) was 
used to quantify the abundance of transcripts by qRT-PCR, not distinguishing between 
HSPA1A and HSPA1B transcripts. The following primers were used: forward primer 5’-
AGGACATCAGCCAGAACAAG-3’ and reverse primer 5’–
CTGGTGATGGACGTGTAGAAG-3’. Primers for GAPDH were described previously 
(Xue et al., 2013). 
Purification of biotinylated proteins for mass spectrometry analysis 
Thirty million HEK293 cells were pelleted and lysed in 10 mL BugBuster lysis buffer 
(Novagen) containing protease inhibitor cocktail and Benzonase Nuclease (Novagen). 
After centrifugation, the supernatant was filtered through a 22-µm membrane and loaded 
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on a 2-mL monomeric avidin column (Thermo Scientific). Biotinylated proteins were 
eluted with 0.1 M glycine (pH 2.8) and concentrated using a 5,000 MWCO concentrator 
(Corning). Protein samples were resolved on polyacrylamide gels and stained with 
Coomassie Blue. 
Mass spectrometry  
For identification of immune-precipitated proteins in Co-IP assay, the band observed in 
the HLCS overexpression group rather than in the control group was cut and prepared for 
mass-spectrometry assay as described previously (Shevchenko, Tomas, Havlis, Olsen, & 
Mann, 2006).  All mass-spectrometry assays were performed in the proteomic and 
metabolomics core facility in Redox Biology Center at the University of Nebraska-
Lincoln. The same protocol was used for samples purified by avidin columns. The 
acquired spectrum was compared to the human reference proteome using Mascot 
(www.matrixscience.com) (Perkins et al., 1999).  
Biotinylation assay 
His-tagged HSP72 or mutants were mixed with GST-tagged HLCS or GST tag alone and 
processed as previously described (Bao et al., 2011). Proteins were resolved using 
polyacrylamide gels and probed with streptavidin (Pestinger, Wijeratne, Rodriguez-
Melendez, & Zempleni, 2011). Equal loading was confirmed by anti-His (Fig. 4, Abcam) 
or Coomassie Blue (Fig. 5). 
RANTES stimulation 
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HEK293 cells were seeded in in 24-well plates (0.5x10
6
 cells/500 μL medium) for 24 hrs 
prior to stimulation with enzymatically biotinylated recombinant HSP72 and HSP72K112-
415R mutant, which were prepared as described in “Biotinylation assay.” Cells were 
stimulated for 20 hrs before collection for analysis of RANTES transcripts. 
Statistical analysis 
Normality was tested by normal quantile plot, and homogeneity of variances was tested 
by F-test. Student’s t-test was used for pairwise comparisons. One-way ANOVA and 
Fisher’s least significance difference (LSD) test were used when more than two groups 
were compared. Means and standard deviations are reported. Differences were considered 
significant if p<0.05. 
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Figures and legends 
 
Figure 1. HLCS interacts physically with HSP72 in HEK293 cells. (A)  Lysates from 
cells overexpressing Flag- and Myc-tagged HLCS and normal controls (-) were 
immunoprecipitated with anti-Myc; proteins in precipitates were resolved on 
polyacrylamide gels and probed with anti-HSP72 and anti-Myc. Samples prior to 
precipitation served as input controls was and were probed with anti-HSP72 and anti-
GAPDH. (B) Same as in panel A, but proteins were precipitated using anti-Flag, gels 
were stained with Coomassie blue, and cut-out pieces (marked by “HLCS” and “HSP72”) 
were analyzed by LC/MS/MS. Probability scores for protein identities were 1170 and 242 
for HLCS and HSP72, respectively.  
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Figure 2. HLCS overexpression does not cause an increase in HSP72 expression in 
HEK293 cells. (A) Proteins in cell lysates from cells overexpressing Flag- and Myc-
tagged HLCS and normal controls (-) were resolved using polyacrylamide gels and 
transblots were probed using anti-HSP72 and anti-GAPDH (control). The abundance of 
HSP72 was quantified by band densitometry and normalized for GAPDH (p-value=0.905; 
n=3 independent experiments); the insert depicts a typical gel. (B) total HSP72 mRNA 
abundance (HSPA1A + HSPA1B) was quantified using RT-PCR. Error bars represent the 
standard deviation for three independent runs (*p-value=0.0086). (C) Semi-quantitative 
PCR analysis of HSPA1A and HSPA1B full-length transcripts using cDNA from cells 
overexpressing Flag- and Myc-tagged HLCS and normal controls. 
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Figure 3. HSP72 interacts physically with HLCS in limited proteolysis assays. 
Recombinant GST-tagged HLCS was incubated with recombinant His-tagged HSP72 
prior to treatment with trypsin. At timed intervals, aliquots were collected, resolved using 
polyacrylamide gel electrophoresis and stained with Coomassie blue. Controls were 
created by incubating His-tagged HSP72 with GST alone. 
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Figure 4. Lysines in HSP72 are targets for biotinylation by HLCS. (A) His-tagged HSP72 
was incubated with GST-tagged HLCS, biotin, and co-factors for enzymatic biotinylation. 
Proteins were resolved by polyacrylamide gel electrophoresis, and HSP72-bound biotin 
was probed using streptavidin. Controls were prepared by omitting HLCS. Equal loading 
was confirmed using anti-His. (B) Biotinylated proteins from HEK293 cell lysates were 
enriched using avidin columns, desalted, resolved by gel electrophoresis, and cut-out 
pieces were analyzed by LC/MS/MS. Five biotinylation sites were identified in HSP72 
and the scores represent peptide probability scores from Mascot analysis. Two distinct 
scores were obtained for K112 and K128 dually biotinylated HSP72 in independent 
experiments, and both scores are shown.  
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Figure 5. Mutations of biotinylation sites in HSP72 do not affect interactions with HLCS. 
(A) HSP72 biotinylation sites are not evolutionary conserved. The HMM logo was 
retrieved by searching the Pfam database with the protein sequence of HSP72 (NCBI 
Accession NP_005336.3); amino acids flanking the biotinylation site are also shown. (B) 
Limited proteolysis assays were conducted as described for Fig. 3, but HSP mutants were 
assessed. 
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Figure 6. Biotinylation of wild-type and mutant eHSP72 causes an increase in RANTES 
transcription in HEK293 cells. (A) HEK293 cells were cultured in the presence of the 
indicated amount of biotinylated His-tagged HSP72 for 20 h. Biotinylated HSP72 was 
prepared by incubation with HLCS prior to cell cultures. Negative controls were prepared 
by omitting HLCS in the biotinylation reaction and adding 0.5 μM HSP72 to cell cultures 
(HSP72-ctl-0.5 μM). An HLCS control was created by adding an equimolar amount of 
recombinant HLCS without recombinant HSP72 to cell cultures. (B) As described for 
panel A, but the HSP72K112-415R mutant was substituted for wild-type HSP72. 
Means±standard deviations are reported (
a,b,c
Bars not sharing the same letter are 
significantly different; p < 0.05; n=3).  
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Abstract 
The protein biotin ligase, holocarboxylase synthetase (HLCS), is a chromatin chromatin 
that interacts physically with the DNA methyltransferase DNMT1, the methylated 
cytosine binding protein MeCP2, and the histone H3 K9-methyltransferase EHMT1, all 
of which participate in folate-dependent gene repression. Here we tested the hypothesis 
that HLCS mediates epigenetic synergies between the biotin and folate in the repression 
of pro-inflammatory cytokines and long-terminal repeats (LTRs). Biotin and folate 
supplementation could compensate for each other’s deficiency in the repression of LTRs 
in Jurkat and U937 cells. For example, when biotin-deficient Jurkat cells were 
supplemented with folate, the expression of LTRs decreased by >70%. Epigenetic 
synergies were more complex in the regulation of cytokines compared with LTRs. For 
example, the abundance of TNF-α was 100% greater in folate- and biotin-supplemented 
U937 cells compared with biotin-deficient and folate-supplemented cells. The NF-κB 
inhibitor curcumin abrogated the effects of folate and biotin in cytokine regulation, 
suggesting that transcription factor signaling adds an extra layer of complexity to the 
regulation of cytokine genes by epigenetic phenomena. We conclude that biotin and 
folate synergize in the repression of LTRs, and that these interactions are probably 
mediated by HLCS-dependent epigenetic mechanisms. In contrast, synergies among 
biotin, folate, and HLCS in the regulation of cytokines need to be interpreted in the 
context of transcription factor signaling. 
Key words: biotin; holocarboxylase synthetase; folate; interleukin-6; methyl donors; 
synergies; tumor necrosis factor α.  
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Introduction 
The roles of nutrients in immune function are undisputed, including the vitamins biotin 
and folate. For example, children with hereditary abnormalities of biotin metabolism 
developed candida dermatitis, had absent delayed-hypersensitivity skin-tests responses, 
IgA deficiency, and subnormal percentages of T lymphocytes in peripheral blood (Cowan 
et al., 1979). In biotin-deficient rats, the synthesis of antibodies is reduced (Kumar & 
Axelrod, 1978). Biotin deficiency in mice decreases the number of spleen cells and the 
percentage of B lymphocytes in spleen (Báez-Saldaña, Díaz, Espinoza, & Ortega, 1998), 
inhibits thymocyte maturation (Baez-Saldana & Ortega, 2004), and increases the 
production of pro-inflammatory cytokines (Kuroishi et al., 2009). Likewise, severe folate 
deficiency inhibits the proliferation of primary human CD8
+
 T lymphocytes in vitro, may 
cause atopy, and impairs natural killer cell-mediated cytotoxicity in rats (Courtemanche, 
Elson-Schwab, Mashiyama, Kerry, & Ames, 2004; Husemoen et al., 2006; Kim, Hayek, 
Mason, & Meydani, 2002). However, evidence also suggests that an intake of more than 
400 μg/day folate may impair natural killer cell cytotoxicity in postmenopausal women 
(Troen et al., 2006), i.e., both folate deficiency and supplementation can be detrimental to 
immune function. 
The interpretation of the effects of nutrition on immune function is further complicated 
by the fact that recommendations for nutrient intake are largely based on considering 
nutrients in isolation as opposed to taking into account their synergies and interactions 
(National, 1998). Notable exceptions include vitamins B6 and E and to some extent folate. 
In previous studies we laid the groundwork for establishing synergistic mechanisms 
between biotin and folate in gene regulation (Fig. 1). In these previous studies we 
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demonstrated that the folate-dependent methylation of DNA is a pre-requisite for the 
subsequent binding of the protein biotin ligase, holocarboxylase synthetase (HLCS), to 
chromatin but that DNA methylation does not depend on HLCS-dependent events (Chew 
et al., 2008). We further demonstrated that HLCS interacts physically with the DNA 
methyltransferase DNMT1 and the methylated cytosine binding protein MeCP2 (Xue, 
Wijeratne, & Zempleni, 2013). While histone biotinylation marks are overrepresented in 
repressed loci, these marks are very rare in the epigenome and, therefore, can hardly 
explain the robust correlation between those marks and gene repression (Chew et al., 
2008; Gralla, Camporeale, & Zempleni, 2008; Kuroishi, Rios-Avila, Pestinger, Wijeratne, 
& Zempleni, 2011). Importantly, HLCS also interacts physically with the histone H3 K9-
methyltransferase (H3K9me) EHMT1 and catalyzes the biotinylation of K161 in the 
HLCS-binding domain in EHMT1, thereby strengthening the interaction between the two 
proteins (Li, Hassan, Moriyama, & Zempleni, 2013). When the biotinylation site in 
EHMT1 is mutated or deleted, the physical interaction between the two proteins is 
reduced. Importantly, H3K9me marks are abundant in the epigenome and play an 
undisputed role in gene repression (Kouzarides & Berger, 2007). HLCS knockdown 
causes a depletion of H3K9me marks and, consequently, de-represses loci coding for the 
biotin transporter SMVT, long-terminal repeats (LTRs), and interleukin-2 (Chew et al., 
2008; Gralla et al., 2008; Rios-Avila, Pestinger, & Zempleni, 2012). 
Here we tested the hypothesis that biotin, folate, and HLCS synergize in the regulation of 
pro-inflammatory cytokines and LTRs, using vitamin concentrations in cell cultures that 
are nutritionally relevant. We assessed the regulation of the following loci and genes. (a) 
LTR transcripts were tested, because their regulation depends on biotin, HLCS, and 
70 
 
 
 
methylation events (Chew et al., 2008; Martens et al., 2005a), and de-repression of LTRs 
impairs genome stability (Kazazian, 2004; Waterston et al., 2002). (b) Tumor necrosis 
factor alpha (TNF-α) and interleukin-6 (IL-6) were tested because folate supplementation 
represses the lipopolysaccharide-induced transcription of TNF-α in RAW264.7 
macrophages (Feng, Zhou, Xia, & Ma, 2011) whereas folate deficiency increases the 
expression of TNF-α (Kolb & Petrie, 2013); both TNF-α and IL-6 are inducible by  NF-
κB (Oshima & Oshima, 2012) and play a central role in the pathogenesis of Crohn’s 
disease (Fujitake et al., 2013) and fat-induced liver inflammation (Park et al., 2010).  
Results 
Efficacy of treatment 
The abundance of biotinylated carboxylases in Jurkat cells responded well to changes in 
biotin concentrations in culture media (Fig. 2). In U937 cells, the abundance of 
biotinylated carboxylases was not different in biotin-sufficient and biotin-supplemented 
cells, suggesting that carboxylases were saturated with coenzyme at physiological 
concentrations of biotin in this macrophage cell line. Of note, propionyl-CoA carboxylase 
was barely detectable in U937 cells. Likewise, acetyl-CoA carboxylases 1 and 2 were 
barely detectable in both cell lines, consistent with previous observations in immune cells 
(Manthey, Griffin, & Zempleni, 2002). Collectively, these observations are consistent 
with the notion that changes in biotin supply affected cellular biotin. 
The levels of SAM and SAH in cell cultures were below the detection limit of the 
reversed-phase HPLC system (about 93.3 and 9.6 mmol/L for SAM and SAH, 
respectively) and were not quantified. 
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LTR transcripts 
Supplementation with folate rescues the repression of LTRs in biotin-depleted Jurkat and 
U937 cells. When biotin-deficient Jurkat and U937 cells were supplemented with folate, 
the expression of LTRs decreased by >70% and >30%, respectively (Fig. 3A). Likewise, 
when folate-deficient Jurkat cells were supplemented with biotin, the expression of LTRs 
decreased by >50% (Fig. 3B). In contrast, biotin supplementation had no significant 
effect in folate-deficient U937, possibly because cellular biotin status cannot be increased 
in biotin-supplemented compared with biotin-sufficient macrophages. Collectively, these 
observations suggest that biotin can rescue folate-deficient cells and vice versa, consistent 
with the theory of synergies between the two micronutrients.  
Pro-inflammatory cytokines 
The effects of biotin and folate on the expression of TNF-α and IL-6 presented a much 
more complex and less coherent picture than that of LTRs; the cytokine data can be 
summarized as follows. The expression of TNF-α increased significantly in response to 
biotin supplementation when folate-supplemented U937 cells were cultured in biotin-
defined media (Fig. 4A). In contrast, the expression of TNF-α decreased significantly in 
response to folate supplementation when biotin-supplemented U937 cells were cultured 
in folate-defined media (Fig. 4B). However, the expression of TNF-α was not affected by 
biotin in folate-supplemented Jurkat cells (data not shown), consistent with the notion 
that cells of the T-cell lineage play a minor role in TNF-α production. Subsequent studies 
of cytokines focused on the myeloid U937 cells rather than T-cells, because innate 
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phagocytic cells, i.e., macrophages, are the primary source of TNF-α in immune defense 
(Allie et al., 2013). 
Similar to the effects described for TNF-α, the expression of IL-6 increased in response 
to biotin supplementation when folate-supplemented U937 cells were cultured in biotin-
defined media, although the differences between biotin-sufficient and biotin-
supplemented media did not reach statistical significance (Fig. 5). 
Biotin-dependent cell signals include the transcription factors Sp1/Sp3, NF-κB and 
Fos/Jun (Griffin, Rodriguez-Melendez, & Zempleni, 2003; Rodriguez-Melendez, Griffin, 
Sarath, & Zempleni, 2005; Rodriguez-Melendez, Schwab, & Zempleni, 2004). Curcumin 
blocks NF-κB signaling through inhibiting the IκB kinase alpha/beta (Meng, Yan, Deng, 
Gao, & Niu, 2013; Singh & Aggarwal, 1995). Curcumin (diferuloylmethane) abolished 
effects of biotin and folate in the regulation of TNF-α (data not shown) and IL-6 (Fig.5), 
suggesting that the activation of biotin-dependent transcription factors preceed the 
epigenetic events that regulate cytokine expression. Jurkat cells do not express IL-6 and 
were not considered for analysis. 
 
Discussion 
Here we report novel synergies between the vitamins folate and biotin in gene regulation, 
including genes coding for pro-inflammatory cytokines. For LTRs, the data are 
unambiguous and suggest that folate and biotin supplementation can compensate for each 
other’s deficiency in mediating LTR repression to a quantitatively meaningful extent. 
This observation is firmly grounded in our previous reports that the binding of HLCS to 
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human chromatin depends on prior folate-dependent DNA methylation and that folate-
dependent creation of H3K9me histone repression marks depends on HLCS and perhaps 
HLCS-dependent biotinylation events (Li et al., 2013; Xue et al., 2013). The 
unambiguous nature of the LTR data is probably due to the tight regulation of these 
repeats through epigenetic mechanisms including various methylation marks (Martens et 
al., 2005b). 
Previous studies suggest that the expression of TNF-α increases and decreases in folate-
free and folate-supplemented media, respectively, in macrophages (Feng et al., 2011; 
Kolb & Petrie, 2013). However, the levels of folate used in these studies lacked 
physiological relevance, because zero folate is not consistent with survival and millimolar 
concentrations greatly exceed levels observed in human plasma (George et al., 2002; 
Selhub, Morris, & Jacques, 2007). Here we demonstrated for the first time that 
biologically relevant concentrations of folate and biotin decrease and increase, 
respectively, the expression of TNF-α. We propose that cytokines, unlike LTRs, are 
regulated by a complex network involving numerous transcription factors, and that 
changes in biotin- and folate-dependent transcription factors need to be considered when 
investigating synergies between the two vitamin in gene regulation. For example, biotin 
deficiency – and nutrient deficiency cell stress in general, causes activation of NF-κB 
(Rodriguez-Melendez et al., 2004). In this study, curcumin (diferuloylmethane) abrogated 
the effects of biotin and folate on cytokine expression, consistent with the theory that 
transcription factor signaling is an important component when evaluating epigenetic 
synergies between vitamins. 
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Synergies between biotin and folate are important for human health, based on the 
following rationale. LTRs make up about 8% of the human genome and at least 51 LTRs 
are transcriptionally competent (Buzdin, Kovalskaya-Alexandrova, Gogvadze, & 
Sverdlov, 2006). Repetitive elements such as LTRs pose a burden to genome stability, as 
their mobilization facilitates recombination between non-homologous loci, leading to 
chromosomal deletions and translocations (Kazazian, 2004; Martens et al., 2005a). 
Mobilization of LTR transposons is associated with 10% of all spontaneous mutations in 
mice (Waterston et al., 2002). De-repression of LTRs may impair genome stability 
through insertional mutagenesis, recombination events that cause translocations and other 
rearrangements, de-regulation of genes in the host genome mediated by LTR promoter 
activity, and antisense effects if transcription extends into exon sequence downstream of 
the transposon (Yoder, Walsh, & Bestor, 1997). Likewise, the tight regulation of pro-
inflammatory cytokines is important to ensure an appropriate response of the immune 
system to external challenges such as infection (Dhar & Ogra, 1985). An unregulated 
continued expression of pro-inflammatory cytokines is associated with diseases such as 
rheumatoid arthritis (Choy, 2012) and inflammatory bowel disease (MacDonald, 
Biancheri, Sarra, & Monteleone, 2012), which affect a significant portion of the 
population in western societies (Centers, 2010, 2011).  
We conclude that biotin and folate synergize in the repression of LTRs, and that these 
interactions are probably mediated by HLCS-dependent epigenetic mechanisms. In 
contrast, synergies among biotin, folate, and HLCS in the regulation of cytokines need to 
be interpreted in the context of transcription factor signaling. We are currently creating a 
75 
 
 
 
conditional HLCS knockout mouse model, so that future studies of epigenetic synergies 
can be conducted in a whole animal model at a mechanistic level. 
 
Materials and Methods 
Cell cultures 
Human T lymphoma Jurkat cells and monocytic myeloid U937 cells were obtained from 
American Type Culture Collection (Manassas, VA, USA). Cells were cultured in biotin- 
and folate defined media. Culture media were prepared using customized RPMI-1640 
(Hyclone, Ogden, UT, USA), which was free of biotin, folate, and the methyl donor L-
methionine. RPMI-1640 was mixed with 10% of biotin-depleted fetal bovine serum (FBS) 
(Atlanta Biologicals, Lawrenceville, GA, USA) prepared as described previously and 
antibiotics (Manthey et al., 2002). Chemically pure L-methionine was added back to 
produce a concentration of 10 μmol/L methionine representing the levels in normal 
human plasma (Shinohara, Hasegawa, Tagoku, & Hashimoto, 2001). The endogenous 
levels of folate (22.7 nmol/L) and methionine (2.7 μmol/L) in FBS were quantified in the 
Physicians’ Laboratories (Omaha, NE, USA) and the Metabolomics core facility at the 
University of Nebraska-Lincoln, respectively, and taken into account when adjusting 
nutrient levels in culture media. Biotin was added to media to produce the following 
concentrations (nmol/L): 0.025 (deficient), 0.25 (sufficient) and 10 (supplemented) 
(Mock, Lankford, & Mock, 1995; Zempleni, Helm, & Mock, 2001). Folate levels were 
adjusted to 4.9, 14 and 32 nmol/L, representing deficient, physiological and 
supplemented serum levels, respectively, in women living in regions without mandatory 
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folate fortification (George et al., 2002).  Cells were cultured in specified defined 
medium for consecutive 14 days, and were re-suspended in fresh medium every 48 hrs. 
The secretion of cytokines was induced by treatment with 50 µg/L phorbol 12-myristate 
13-acetate (PMA) and 2 mg/L phytohemagglutinin (PHA) (Manthey et al., 2002). At 
timed intervals (see Results), aliquots were collected for analysis of mRNA by 
quantitative real-time PCR (qRT-PCR). 
In select experiments NF-κB signaling was inhibited by treatment with curcumin 
(diferuloylmethane), which is an inhibitor of the IκB alpha/beta kinase (Meng et al., 2013; 
Singh & Aggarwal, 1995). Briefly, cells were treated 5 μmol/L curcumin (final 
concentration; Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 hr before addition 
of PMA and PHA to culture media. 
Determination of biotin and folate status 
Biotinylated carboxylases are well-established markers for biotin status (Zempleni, 
Wijeratne, & Kuroishi, 2012) and were assessed by streptavidin gel electrophoresis as 
described previously (Pestinger, Wijeratne, Rodriguez-Melendez, & Zempleni, 2011). 
The ratio of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH), two 
metabolites of methyl donors, represented the methylation index (Stabler & Allen, 2004) 
and the intracellular concentrations of SAM and SAH were measured by reversed-phase 
high-performance liquid chromatography (HPLC) and a photodiode array detector. 
Quantitative real-time PCR 
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qRT-PCR analysis of mRNA coding for LTRs and cytokines was conducted as described 
previously (Pestinger et al.). The following primers were used. LTR R/U5 transcripts: 5’-
GCGGGCAGCAATACTGCTTTGTAA-3’ (forward) and 5’-
ACCAGCGTTCAGCATATGGAGGAT-3’ (reverse); TNF-α: 5’–
ACTTTGGAGTGATCGGCC-3’ (forward) and 5’-GCTTGAGGGTTTGCTACAAC-3’ 
(reverse); IL-6: 5’-CCACTCACCTCTTCAGAACG-3’ (forward) and 5’-
CATCTTTGGAAGGTTCAGGTTG-3’ (reverse); and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH): 5’-TCCACTGGCGTCTTCACC-3’ (forward) and 5’-
GGCAGAGATGATGACCCTTT-3’ (reverse). GAPDH was used to normalize for 
amplification efficiency. Note that the transcript sequences are nearly identical in the 54 
transcriptionally active LTRs in the human genome (Buzdin et al., 2006). Therefore, the 
LTR transcript abundance reported here represents the total of all transcriptionally active 
LTRs. Transcription in human can initiate in both the U5 region and the R/U5 boundary 
in LTRs. The epigenetic regulation is the same for both transcripts (Chew et al., 2008); 
we quantified R/U5 transcripts because they mark active retro-transcription and retro-
transposition events (Buzdin et al., 2006; Kovalskaya, Buzdin, Gogvadze, Vinogradova, 
& Sverdlov, 2006). 
Statistical analysis 
Normality was tested by normal quantile plot (Thode, 2002), and homogeneity of 
variance was analyzed by F-test (Hand & Nagaraja, 2003). Data sets with a p-value<0.05 
in the F-test were log transformed before subsequent statistical analysis. Student’s t-test 
was used when comparing two groups. When more than two groups were compared, one-
way ANOVA and Fisher’s least significant difference (LSD) posthoc test was used. 
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Means and standard deviations from independent samples are reported. Different letters 
indicated significant difference with p-value<0.05. All calculations were based on three 
independent experimental repeats. Error bars represented standard deviations. 
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Figures and legends 
 
Figure 1. Synergies among biotin, folate, and chromatin proteins in gene repression. 
Methyl donors may include folate, methione and perhaps choline and betaine. 
Abbreviations: bio, biotin; me, methyl.  
 
Figure 2. The abundance of biotinylated carboxylases depends on biotin in culture media 
in Jurkat and U937 cells. Abbreviations: ACC1&2, acetyl CoA carboxylases 1 and 2; PC, 
pyruvate carboxylase; MCC, methylcrotonyl CoA carboxylase; PCC, propionyl-CoA 
carboxylase. 
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Figure 3. Folate and biotin can compensate for each other’s deficiency in the repression 
of LTRs in Jurkat and U937 cells. (A) Biotin-deficient cells were supplemented with 
folate. (B) Folate-deficient cells were supplemented with biotin. 
a,b
Columns not sharing 
the same letter are significantly different in the same cell line (p<0.05, n=3). 
Abbreviations: DEF, deficient; SUP, supplemented. 
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Figure 4. Biotin and folate have opposing effects in the regulation of TNF-α transcription 
in U937 cells. (A) Folate-supplemented cells were cultured in biotin-defined medium and 
stimulated with PMA/PHA. (B) Biotin-supplemented cells were culture in folate-defined 
medium and stimulated with PMA/PHA. 
a,b,c
Columns not sharing the same letters are 
significantly different in the same dataset (p<0.05, n=3). Abbreviations: DEF, deficient; 
SUF, sufficient; SUP, supplemented. 
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Figure 5. Curcumin abrogates the biotin-dependent expression of IL-6 to in U937 cells. 
a,b,c,d
Columns not sharing the same letters are significantly different (p<0.05, n=3). 
Abbreviations: DEF, deficient; SUF, sufficient; SUP, supplemented. 
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OUTLOOKS 
Even though the HLCS mediated epigenetic regulation and protein has been well-
characterized in cell cultures, creating a conditional knockout HLCS (CKO) mouse 
model will be of great interest to validate the cell-culture derived results and perform 
animal studies otherwise cannot be achieved in vitro or ex vivo.  We are in the process of 
creating HLCS -CKO knock-out mice using the following protocol:  
(i) Construct the HLCS-CKO vector composed of a vector backbone, a loxP 
flanked Exon (E) 8 of HLCS gene, an FRT flanked neomycin cassette, and two homology 
arms with sequences homologous to the genomic sequences flanking E8. The backbone 
vector illustrated in Figure 1 is PL253 (http://recombineering.ncifcrf.gov/Plasmid.asp); the 
backbone vector donating the neomycin cassette is PL451 
(http://recombineering.ncifcrf.gov/Plasmid.asp ). 
 
Figure 1. Creation of HLCS conditional knock out (CKO) mouse. The plasmid was 
created to add a loxP site flanking each side of the E8 sequence of HLCS. The neomycin 
cassette is flanked by two FRT sequences. The homology arms flanking the left loxP site 
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and the right FRT site facilitates chromosomal recombination for substitute the wild-type 
E8 sequence with the loxP flanked E8 followed by a neomycin cassette. The insert 
depicts the offspring pups (color in agouti or black) from the chimera breeder mice. 
 
 (ii) Linearize the HLCS-CKO construct and introduce into the A129 mouse 
embryonic stem (ES) cells through electroporation. Select positive clones with successful 
homologous recombination using the positive (G418 resistance conferred by neomycin 
cassette) and negative selection (Ganciclovir resistance due to loss of HSV-TK sequence 
as denoted in Figure 1) markers provided by the vector. 
 (iii) Inject the positive ES cells into the blastocysts of C57BL/6J mice for 
breeding of chimera mice. 
89 
 
 
 
 
 (iv) Cross the chimera offsprings with C57BL/6J mice to confirm germ line 
transmission (Figure 2). 
 
Figure 2. Genotype to comfirm the germline transmission of modified HLCS 
sequence. (A) Two pairs of primers were designed. The overlapping primers amply a 
fragment overlapping the upstream loxP site, thereby creating amplicon of two sizes, one 
from the wild-type genomic DNA (300 bp), the other from the transgenic copy (427). The 
negative control is the genomic DNA prepared from the suggrogate breeder A129 strain. 
The loxP and FRT primers amplify a fragment spaning from the middle of the flanked E8 
sequence to the neomycin sequence, thereby creating an amplicon (1485 bp) only from 
the transgenic copy of genomic DNA. (B) DNA electrophoresis was performed to 
visualize the identified transgenic mice. (Pos.= positive control; Neg.= negative control; 
Trans.= transgenic mice)  
 
A. 
B. 
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 (v) (Current stage of the project) CKO in the C57BL/6J background will be 
created by backcrossing with C57BL-6J breeders for ten generations, and genotyping will 
be conducted in each generation (Fig. 2). 
 (vi) The neomycin cassette will be removed by crossing transgenic mice with FLP 
transgenic mice for two generations. The FLP transgenic mice express Flp-recombinase, 
which will remove the neomycin cassette, leaving one FRT site (Figure 3). 
 (vii) Homozygous offspring will be created by inbreeding the transgenic mice for 
three generations. 
 (viii) The derived transgenic mice will be crossed with the Cre transgenic mice in 
order to remove the loxP flanked E8, leaving a loxP site, thereby creating the HLCS-
CKO mice (Figure 3).
 
Figure 3. Removal of the neomycin cassette and loxP flanked E8 by Flp recombinase 
and Cre recombinase, respectively.  
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With the establishment of the homozygous transgenic strain, we would be able to knock 
out HLCS gene in desired tissues by crossing the homozygous transgenic mice derived 
from step (vii) with a Cre transgenic mice expressing Cre recombinase in the desired 
tissue. For achieving inducible knockout, a Cre transgenic mice with inducible elements 
in their genome could be used, where the expression of Cre recombinase is controlled by 
inducing reagents. As a powerful tool, the HLCS-CKO mice will enable us to investigate 
the function of HLCS in different tissues, as well as study the health impacts of tissue-
specific HLCS knockout on the whole body.
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APPENDIX 
--- Raw data for each chapter 
Table 1.(Chapter I) The effects of HLCS on LTR repression dependent on DNA 
methylation. 
Panel A 
 
RT-PCR Ct values normalized by histone H3 
control and input 
Cell-line Repeat 1 2 3 4 5 
FLAG/Myc-HLCS LTR15 1.95 1.02 1.52 2.77 1.02 
Control LTR15 0.61 0.62 0.51 0.62 0.32 
FLAG/Myc-HLCS Chr.1 alpha sat. 0.17 0.09 0.13 0.12 0.07 
Control Chr.1 alpha sat. 0.15 0.16 0.05 0.12 0.03 
FLAG/Myc-HLCS Chr.4 alpha sat. 0.19 0.11 0.14 0.19 0.07 
Control Chr.4 alpha sat. 0.14 0.14 0.07 0.18 0.03 
FLAG/Myc-HLCS GAPDH 0.66 0.33 0.66 0.64 0.41 
Control GAPDH 0.22 0.35 0.26 0.39 0.1 
FLAG/Myc-HLCS Apobec1 1.38 0.72 1.42 1.15 0.99 
Control Apobec1 0.27 0.43 0.4 0.43 0.09 
       
Panel B 
 
RT-PCR Ct values normalized 
by GAPDH control and 
untransfected control 
  Treatment Repeat 1 2 3 
  5-Azacytidine U5 1.401 1.249 1.332 
  Control U5 0.133 0.135 0.122 
  5-Azacytidine R-U5 1.193 1.045 1.115 
  Control R-U5 0.152 0.135 0.144 
  5-Azacytidine Chr1alpha 1.712 1.26 2.429 
  Control Chr1alpha 0.121 0.143 0.121 
  5-Azacytidine Chr4alpha 1.969 0.935 1.525 
  Control Chr4alpha 0.146 0.163 0.123 
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Table 2. (Chapter II) HLCS overexpression does not cause an increase in HSP72 
expression in HEK293 cells. 
Panel A 
 
Band densitometry values 
normalized by GAPDH 
control 
Cell-line Repeat 1 2 3 
FLAG/Myc-
HLCS 
 
10.03 5.93 9.89 
Control   10.49 8.5 6.11 
     
     
Panel B 
 
RT-PCR Ct values 
normalized  by GAPDH 
control 
Cell-line Repeat 1 2 3 
FLAG/Myc-
HLCS 
 
1.03 0.99 0.99 
Control   1.57 1.57 1.59 
 
Table 3. (Chapter II) Biotinylation status of HSP72 and its mutants. 
  
Band densitometry values 
normalized by blue staining 
Proteins Repeat 1 2 3 
HSP72 
 
0.822 0.745 0.978 
HSP72K112,128R 
 
0.863 0.559 0.850 
HSP72K348,361,415R 
 
0.761 0.689 1.050 
HSP72K112-415R   0.546 0.750 1.203 
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Table 4. (Chapter II) Biotinylation of wild-type and mutant eHSP72 causes an 
increase in RANTES transcription in HEK293 cells. 
 
 
  
Panel A 
 
RT-PCR Ct values 
normalized by GAPDH 
control 
Treatment Repeat 1 2 3 
HSP72-0.1μM 
 
112.01 26.28 19.64 
HSP72-0.5μM 
 
110.91 132.70 81.32 
HSP72-1.0μM 
 
134.43 264.68 181.02 
HSP72-ctl-0.5μM 
 
25.92 127.04 65.39 
HLCS    84.06 154.22 241.01 
     
     
     
Panel B 
 
RT-PCR Ct values 
normalized by GAPDH 
control 
Treatment Repeat 1 2 3 
HSP72K112-415R-0.1μM 
 
166.02 57.46 251.31 
HSP72K112-415R-0.5μM 
 
240.02 168.91 100.66 
HSP72K112-415R-1.0μM 
 
320.55 291.94 201.24 
HSP72K112-415R-ctl-0.5μM   78.73 22.38 91.03 
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Table 5. (Chapter III) Folate and biotin can compensate for each other’s deficiency 
in the repression of LTRs in Jurkat and U937 cells.  
    
RT-PCR Ct values 
normalized by GAPDH 
control 
Cell-
line Biotin Folate Repeat 1 2 3 
Jurkat 
Deficient Deficient   21.61 20.16 20.16 
Deficient Supplemented 
 
8.98 9.62 8.38 
Supplemented Deficient   5.4 7.64 5.04 
U937 
Deficient Deficient 
 
22.11 29.18 33.51 
Deficient Supplemented 
 
34.3 36.76 39.4 
Supplemented Deficient   14.59 19.25 17.96 
 
Table 6. (Chapter III) Biotin and folate have opposing effects in the regulation of 
TNF-α transcription in U937 cells. 
Panel A 
   
RT-PCR Ct values 
normalized by GAPDH 
control 
Cell-
line Biotin Folate Repeat 1 2 3 
U937 
Deficient 
Supplemented 
  64 50.5 33.1 
Sufficient   79 56.3 90.7 
Supplemented   111.5 115.6 132.8 
       
       
       
       
Panel B 
   
RT-PCR Ct values 
normalized by GAPDH 
control 
Cell-
line Biotin Folate Repeat 1 2 3 
U937 Supplemented 
Deficient   265 401.7 101.4 
Physiological   181.13 230.7 137.2 
Supplemented   111.5 115.6 132.8 
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Table 7. (Chapter III) Curcumin abrogates the biotin-dependent expression of IL-6 
to in U937 cells. 
     
RT-PCR Ct values 
normalized by GAPDH 
control 
Cell-
line Treatment Biotin Folate Repeat 1 2 3 
U937 
Control 
Deficient 
Supplem-
ented 
  64 50.5 33.1 
Curcumin 
 
27.9 40.8 42.6 
Control 
Sufficient 
 
79 56.3 90.7 
Curcumin 
 
20.4 32 39.5 
Control Supplemen-
ted  
111.5 115.6 132.8 
Curcumin   59.9 50.4 79 
 
 
